https://curecurrent.com/trials/multiparametric-magnetic-resonance-imaging-of-the-prostate-to-assess-disease-progression-and-genomics-in-patients-underg-55001https://curecurrent.com/trials/phase-ib-ii-platform-study-of-multiple-anti-cancer-agents-in-participants-with-metastatic-prostate-cancer-55002https://curecurrent.com/trials/compass-study-for-metastatic-castration-resistant-prostate-cancer-55003https://curecurrent.com/trials/measuring-circulating-tumor-deoxyribonucleic-acid-tumor-fraction-to-guide-early-177lu-psma-617-treatment-discontinuation-55004https://curecurrent.com/trials/psma-pet-imaging-of-recurrent-prostate-cancer-55005https://curecurrent.com/trials/docetaxel-carboplatin-and-rucaparib-camsylate-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-55006https://curecurrent.com/trials/transrectal-ultrasound-robot-assisted-prostate-biopsy-55007https://curecurrent.com/trials/f-psma-1007-pet-ct-directed-focal-therapy-for-mri-invisible-prostate-cancer-55008https://curecurrent.com/trials/study-of-azd5305-when-given-in-combination-with-new-hormonal-agents-in-patients-with-metastatic-prostate-cancer-55009https://curecurrent.com/trials/ptvg-hp-dna-vaccine-with-or-without-ptvg-ar-dna-vaccine-and-pembrolizumab-in-patients-with-castration-resistant-metastat-55010https://curecurrent.com/trials/micro-ultrasound-in-cancer-active-surveillance-55011https://curecurrent.com/trials/the-prosecca-study-answering-new-questions-in-prostate-cancer-55012https://curecurrent.com/trials/azd2265-compared-with-standard-of-care-in-psma-positive-metastatic-castration-resistant-prostate-cancer-vectra-01-55013https://curecurrent.com/trials/psma-specific-car-t-cell-therapy-55014https://curecurrent.com/trials/safety-and-efficacy-of-therapies-for-metastatic-castration-resistant-prostate-cancer-mcrpc-55015https://curecurrent.com/trials/characterizing-the-genomic-landscape-of-prostate-cancer-in-native-american-populations-nat-geno-55016https://curecurrent.com/trials/cest-for-prostate-biopsy-55017https://curecurrent.com/trials/phase-i-study-of-docetaxel-and-177-lutetium-psma-i-t-in-first-line-treatment-for-patients-with-metastatic-castration-res-55018https://curecurrent.com/trials/multiparametric-ultrasound-for-the-diagnosis-of-clinically-significant-prostate-cancer-55019https://curecurrent.com/trials/virtual-reality-headset-and-or-aromatherapy-for-patients-undergoing-a-transperineal-prostate-biopsy-55020https://curecurrent.com/trials/a-pilot-presurgical-trial-of-regn5678-anti-psma-x-cd28-in-patients-with-high-risk-localized-prostate-cancer-followed-by-55021https://curecurrent.com/trials/placebo-controlled-trial-of-urolithin-a-supplementation-in-men-with-prostate-cancer-undergoing-radical-prostatectomy-uro-55022https://curecurrent.com/trials/truebeam-stereotactic-body-radiotherapy-for-localized-prostate-cancer-55023https://curecurrent.com/trials/response-with-interim-psma-pet-in-metastatic-castration-sensitive-prostate-cancer-for-optimization-of-adaptive-metastasi-55024https://curecurrent.com/trials/prostate-cancer-vaccines-55025https://curecurrent.com/trials/a-study-to-learn-how-enzalutamide-apalutamide-and-bicalutamide-affect-the-way-fezolinetant-is-processed-in-men-with-pros-55026https://curecurrent.com/trials/preclude-infection-events-with-no-prophylaxis-transperineal-biopsy-2-55027https://curecurrent.com/trials/study-of-oral-mrt-2359-with-apalutamide-in-prostate-cancer-55028https://curecurrent.com/trials/sacituzumab-tirumotecan-in-pts-w-nepc-after-progression-on-prior-chemotherapy-55029https://curecurrent.com/trials/best-salvage-treatment-for-high-risk-relapsing-prostate-cancer-peace-9-escalate-rt-55030https://curecurrent.com/trials/a-study-of-the-drugs-talazoparib-and-temozolomide-in-prostate-cancer-55031https://curecurrent.com/trials/a-dose-finding-study-of-debio-4228-in-participants-with-advanced-prostate-cancer-55032https://curecurrent.com/trials/a-single-arm-multicenter-prospective-study-to-evaluate-the-diagnostic-performance-of-prostest-in-men-with-psa-3ng-ml-usi-55033https://curecurrent.com/trials/prorad-5-prostate-radiation-in-5-fractions-phase-ii-five-fraction-radiotherapy-for-patients-with-advanced-prostate-cance-55034https://curecurrent.com/trials/registerpros-a-registry-for-prostate-cancers-55035https://curecurrent.com/trials/weekly-online-ct-or-mr-adaptive-definitive-sbrt-for-regionally-metastatic-prostate-cancer-55036https://curecurrent.com/trials/study-of-amg-509-in-participants-with-metastatic-castration-resistant-prostate-cancer-55037https://curecurrent.com/trials/psca-targeting-car-t-cells-plus-or-minus-radiation-for-the-treatment-of-patients-with-psca-metastatic-castration-resista-55038https://curecurrent.com/trials/a-study-of-talazoparib-with-or-without-enzalutamide-in-people-with-prostate-cancer-who-have-previously-received-abirater-55039https://curecurrent.com/trials/lifestyle-behavior-influences-among-african-american-patients-with-stage-0-iii-prostate-cancer-survivors-and-their-partn-55040https://curecurrent.com/trials/neoadjuvant-enoblituzumab-mga271-in-men-with-localized-intermediate-and-high-risk-prostate-cancer-55041https://curecurrent.com/trials/prospective-exploratory-study-of-fapi-pet-ct-in-prostate-cancer-with-histopathology-validation-55042https://curecurrent.com/trials/prostate-cancer-postoperative-stereotactic-body-radiotherapy-with-adaptive-technology-for-minimizing-toxicity-55043https://curecurrent.com/trials/high-dose-rate-brachytherapy-and-stereotactic-body-radiotherapy-for-the-treatment-of-prostate-adenocarcinoma-55044https://curecurrent.com/trials/adjuvant-chemotherapy-for-high-malignant-prostate-cancer-55045https://curecurrent.com/trials/a-phase-1b-2a-study-of-pocenbrodib-as-monotherapy-and-in-combination-with-darolutamide-in-participants-with-mcrpc-55046https://curecurrent.com/trials/mri-based-focal-intraprostatic-simultaneous-integrated-boost-sib-intensification-with-de-escalated-adaptive-risk-sbrt-fo-55047https://curecurrent.com/trials/comparison-of-prostate-cancer-related-quality-of-life-in-sexually-active-men-with-favourable-intermediate-risk-localised-55048https://curecurrent.com/trials/evaluation-of-targeted-prostate-biopsies-under-mri-tolerance-and-contribution-in-the-therapeutic-decision-exploratory-st-55049https://curecurrent.com/trials/adt-de-escalation-in-selected-high-risk-prostate-cancer-patients-adappt-trial-a-grouq-led-pcs-study-pcs-xiv-55050https://curecurrent.com/trials/schedule-de-escalation-of-177lu-psma-617-for-the-treatment-of-metastatic-castrate-resistant-prostate-cancer-55051https://curecurrent.com/trials/genetic-testing-in-predicting-biomarkers-of-recurrence-in-patients-with-prostate-cancer-undergoing-surgery-55052https://curecurrent.com/trials/computed-tomography-guided-stereotactic-body-radiation-therapy-with-intrafraction-motion-monitoring-for-the-treatment-of-55053https://curecurrent.com/trials/abi-pred-adt-vs-adt-in-psma-positive-conventionally-node-negative-prostate-cancer-55054https://curecurrent.com/trials/ai-algorithm-informed-biopsy-for-prostate-cancer-detection-with-indeterminate-and-low-risk-prostate-mri-lesions-55055https://curecurrent.com/trials/study-to-detect-changes-in-urinary-and-gut-microbiome-during-androgen-deprivation-therapy-and-radiation-therapy-in-patie-55056https://curecurrent.com/trials/treating-prostate-cancer-that-has-come-back-after-surgery-with-apalutamide-and-targeted-radiation-based-on-pet-imaging-55057https://curecurrent.com/trials/efficacy-of-low-intensity-shockwave-vs-radial-wave-for-treatment-of-erectile-dysfunction-and-pelvic-pain-55058https://curecurrent.com/trials/fractionated-and-multiple-dose-225ac-j591-for-progressive-mcrpc-55059https://curecurrent.com/trials/impact-of-an-electronic-health-record-maintenance-alert-on-psa-screening-rates-in-a-10-hospital-integrated-health-system-55060https://curecurrent.com/trials/veteran-peer-navigators-to-promote-shared-decision-making-for-psa-screening-55061https://curecurrent.com/trials/trial-of-docetaxel-samarium-in-patients-with-hormone-refractory-advanced-prostate-cancer-55062https://curecurrent.com/trials/mri-and-gps-informing-choices-for-prostate-cancer-treatment-magic-55063https://curecurrent.com/trials/study-of-dcc-2812-in-participants-with-advanced-genitourinary-cancers-55064https://curecurrent.com/trials/an-observational-study-conducted-in-china-to-evaluate-the-efficacy-and-safety-of-darolutamide-in-combination-with-androg-55065https://curecurrent.com/trials/efficacy-of-acupuncture-in-pain-and-anxiety-during-transperineal-prostate-biopsy-a-prospective-randomized-sham-controlle-55066https://curecurrent.com/trials/a-study-of-arv-766-given-by-mouth-in-men-with-metastatic-prostate-cancer-55067https://curecurrent.com/trials/aggressive-disease-treatment-patterns-and-ctdna-hrr-evaluation-in-high-volume-metastatic-hormone-sensitive-prostate-canc-55068https://curecurrent.com/trials/long-term-extension-study-for-participants-previously-enrolled-in-an-exelixis-sponsored-study-55069https://curecurrent.com/trials/decipher-genomics-resource-for-intelligent-discovery-55070https://curecurrent.com/trials/study-on-olaparib-plus-abiraterone-as-first-line-therapy-in-men-with-metastatic-castration-resistant-prostate-cancer-55071https://curecurrent.com/trials/mri-fusion-biopsy-vs-micro-ultrasound-guided-biopsy-55072https://curecurrent.com/trials/comparing-acupuncture-vs-sham-acupuncture-for-the-management-of-hot-flashes-in-prostate-cancer-patients-receiving-hormon-55073https://curecurrent.com/trials/water-vapor-ablation-for-prostate-cancer-long-term-registry-55074https://curecurrent.com/trials/iccare-consortium-pilot-project-1-feasibility-of-a-point-of-prostate-cancer-diagnosis-intervention-for-newly-diagnosed-b-55075https://curecurrent.com/trials/a-study-of-fg-3246-in-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc-55076https://curecurrent.com/trials/two-studies-for-patients-with-unfavorable-intermediate-risk-prostate-cancer-testing-less-intense-treatment-for-patients-55077https://curecurrent.com/trials/magnetic-resonance-guided-stereotactic-body-radiation-therapy-for-the-treatment-of-prostate-cancer-55078https://curecurrent.com/trials/proof-of-concept-trial-to-assess-the-efficacy-and-safety-of-fezolinetant-in-improving-vasomotor-symptoms-in-men-with-pro-55079https://curecurrent.com/trials/trial-of-modifications-to-radical-prostatectomy-55080https://curecurrent.com/trials/image-guided-radiation-therapy-for-prostate-cancer-55081https://curecurrent.com/trials/two-studies-for-patients-with-high-risk-prostate-cancer-testing-less-intense-treatment-for-patients-with-a-low-gene-risk-55082https://curecurrent.com/trials/testing-the-addition-of-the-drug-apalutamide-to-the-usual-hormone-therapy-and-radiation-therapy-after-surgery-for-prosta-55083https://curecurrent.com/trials/edrn-prostate-mri-biomarker-study-55084https://curecurrent.com/trials/investigating-the-safety-and-diagnostic-performance-of-68ga-nym032-injection-pet-ct-in-men-with-newly-diagnosed-prostate-55085https://curecurrent.com/trials/testing-the-addition-of-the-drug-relugolix-to-the-usual-radiation-therapy-for-advanced-stage-prostate-cancer-the-nrg-pro-55086https://curecurrent.com/trials/a-study-of-patient-preference-between-odm-201-and-enzalutamide-in-men-with-metastatic-castrate-resistant-prostate-cancer-55087https://curecurrent.com/trials/training-on-systemic-and-organ-spec-pm-in-pc-55088https://curecurrent.com/trials/metabolic-interventions-time-restricted-eating-glp1-receptor-agonist-and-heart-healthy-diet-to-improve-cardiometabolic-h-55089https://curecurrent.com/trials/oral-cryotherapy-to-decrease-taste-changes-in-prostate-cancer-patients-receiving-taxane-chemotherapy-55090https://curecurrent.com/trials/gene-expression-in-patients-with-metastatic-prostate-cancer-receiving-cyp-17-inhibition-therapy-55091https://curecurrent.com/trials/low-intensity-extracorporeal-shockwave-therapy-on-penile-rehabilitation-after-robot-assisted-surgical-treatment-of-genit-55092https://curecurrent.com/trials/preoperative-breathing-exercise-training-and-postoperative-delirium-after-robotic-radical-prostatectomy-55093https://curecurrent.com/trials/safety-and-pharmacokinetics-of-odm-208-in-patients-with-metastatic-castration-resistant-prostate-cancer-55094https://curecurrent.com/trials/a-ph-ib-study-of-regn5678-plus-cemiplimab-in-patients-with-mcrpc-55095https://curecurrent.com/trials/effectiveness-of-posluma-pet-scan-for-post-treatment-monitoring-of-prostate-cancer-55096https://curecurrent.com/trials/safety-and-preliminary-diagnostic-performance-of-cu-cu-rax301-in-prostate-cancer-55097https://curecurrent.com/trials/prospective-study-on-the-role-of-radical-prostatectomy-in-oligo-metastatic-hormone-sensitive-prostate-cancer-in-patients-55098https://curecurrent.com/trials/lux-xaluritamig-in-participants-with-metastatic-castrate-resistant-prostate-cancer-and-suboptimal-response-to-lutetium-1-55099https://curecurrent.com/trials/enhanced-genetic-awareness-and-genetic-evaluation-for-men-through-technology-engagement-study-55100https://curecurrent.com/trials/diagnostic-performance-of-non-endorectal-coil-multiparametric-magnetic-resonance-imaging-of-prostate-with-flexible-air-c-55101https://curecurrent.com/trials/copper-cu-64-psma-i-t-pet-imaging-in-men-with-newly-diagnosed-prostate-cancer-55102https://curecurrent.com/trials/comparative-performance-of-64copper-64cu-sar-bis-psma-vs-68ga-psma-11-pet-ct-for-the-detection-of-prostate-cancer-recurr-55103https://curecurrent.com/trials/analysis-of-the-performance-of-psma-emission-tomography-in-patients-with-prostate-cancer-treated-with-hifu-55104https://curecurrent.com/trials/genomic-biomarker-selected-umbrella-neoadjuvant-study-for-high-risk-localized-prostate-cancer-55105https://curecurrent.com/trials/efficacy-and-safety-of-dkf-ma102-in-patients-with-prostate-cancer-55106https://curecurrent.com/trials/evaluation-of-an-mri-based-prostate-cancer-screening-program-visioning-5-year-follow-up-round-visioning-iii-55107https://curecurrent.com/trials/sonablate-hifu-international-registry-for-pc-bph-patients-55108https://curecurrent.com/trials/study-of-janx007-in-subjects-with-metastatic-castration-resistant-prostate-cancer-engager-psma-01-55109https://curecurrent.com/trials/phase-ii-trial-to-investigate-the-safety-and-efficacy-of-four-dosing-regimens-of-otl78-injection-55110https://curecurrent.com/trials/dose-escalated-proton-radiation-therapy-for-high-risk-prostate-cancer-55111https://curecurrent.com/trials/time-restricted-eating-versus-nutritional-counseling-for-the-reduction-of-radiation-or-chemoradiation-tx-side-effects-in-55112https://curecurrent.com/trials/tens-during-transperineal-prostate-biopsy-55113https://curecurrent.com/trials/protons-vs-photons-for-high-risk-prostate-cancer-55114https://curecurrent.com/trials/continence-sexual-function-fitness-and-the-health-of-men-after-surgery-for-prostate-cancer-55115https://curecurrent.com/trials/impact-of-dna-repair-pathway-alterations-on-sensitivity-to-radium-223-in-bone-metastatic-castration-resistant-prostate-c-55116https://curecurrent.com/trials/nivolumab-docetaxel-adt-in-mhspc-patients-with-ddrd-or-inflamed-tumors-55117https://curecurrent.com/trials/radiation-therapy-approaches-for-people-with-prostate-cancer-55118https://curecurrent.com/trials/dose-escalation-study-of-cabozantinib-in-combination-with-lutetium-177-177lu-psma-617-in-patients-with-metastatic-castra-55119https://curecurrent.com/trials/the-effect-of-intrarectal-ice-application-on-pain-anxiety-cortisol-level-complication-development-in-transrectal-ultraso-55120https://curecurrent.com/trials/diffuse-optical-imaging-with-indocyanine-green-solution-in-imaging-pelvic-lymph-nodes-in-patients-with-stage-ii-prostate-55121https://curecurrent.com/trials/uk-genetic-prostate-cancer-study-epidemiology-and-molecular-genetics-studies-55122https://curecurrent.com/trials/structured-periprocedural-nursing-interventions-in-men-undergoing-transrectal-prostate-biopsy-55123https://curecurrent.com/trials/investigation-of-an-intelligent-centre-adaptive-multi-modal-fusion-framework-cad-mmff-to-overcome-unnecessary-prostate-b-55124https://curecurrent.com/trials/nlp-based-feedback-to-improve-risk-comms-and-informed-shared-decision-making-55125https://curecurrent.com/trials/finite-androgen-ablation-with-or-without-abiraterone-acetate-and-prednisone-in-treating-patients-with-recurrent-prostate-55126https://curecurrent.com/trials/enzalutamide-implants-enolen-in-patients-with-prostate-cancer-55127https://curecurrent.com/trials/a-study-to-learn-about-the-investigational-medicine-called-pf-06821497-mevrometostat-in-men-with-mcrpc-who-were-previous-55128https://curecurrent.com/trials/cell-therapy-steap1-cart-with-enzalutamide-for-the-treatment-of-patients-with-metastatic-castration-resistant-prostate-c-55129https://curecurrent.com/trials/cytoreductive-prostatectomy-for-poly-metastatic-hormone-sensitive-prostate-cancer-55130https://curecurrent.com/trials/water-vapor-ablation-for-grade-group-3-prostate-cancer-55131https://curecurrent.com/trials/a-trial-to-evaluate-the-effect-of-applying-leukapheresis-to-enrich-ctcs-in-mpca-patients-55132https://curecurrent.com/trials/mirna-panel-for-pca-diagnosis-55133https://curecurrent.com/trials/watchful-living-in-improving-quality-of-life-in-participants-with-localized-prostate-cancer-on-active-surveillance-and-t-55134https://curecurrent.com/trials/contribution-of-canine-detection-in-the-diagnostic-strategy-of-high-risk-prostate-cancer-prostate-k9-detect-55135https://curecurrent.com/trials/artemicoffee-in-patients-with-rising-psa-55136https://curecurrent.com/trials/a-phase-i-clinical-study-of-hlx3902-in-patients-with-mcrpc-and-other-advanced-tumours-55137https://curecurrent.com/trials/e-mergir-a-digital-psychosexual-intervention-for-the-promotion-of-mental-and-sexual-health-of-prostate-cancer-survivors-55138https://curecurrent.com/trials/a-study-to-assess-bms-986460-in-participants-with-metastatic-castration-resistant-prostate-cancer-55139https://curecurrent.com/trials/a-multi-center-natural-history-of-urothelial-cancer-and-rare-genitourinary-tract-malignancies-55140https://curecurrent.com/trials/sipuleucel-t-sip-t-in-combination-with-n-803-in-metastatic-androgen-pathway-modulation-resistant-mapmr-prostate-cancer-55141https://curecurrent.com/trials/white-button-mushroom-sup-for-the-reduction-of-psa-in-pts-with-biochemically-rec-or-therapy-naive-fav-risk-prostate-ca-55142https://curecurrent.com/trials/tmpsma-02-in-mcrpc-55143https://curecurrent.com/trials/androgen-receptor-antagonist-arn-509-with-or-without-abiraterone-acetate-gonadotropin-releasing-hormone-analog-and-predn-55144https://curecurrent.com/trials/intermittent-fasting-using-a-fasting-mimicking-diet-to-improve-prostate-cancer-control-and-metabolic-outcomes-55145https://curecurrent.com/trials/comprehensive-monitoring-of-men-with-prostate-cancer-cared-for-by-active-surveillance-55146https://curecurrent.com/trials/a-study-to-learn-how-well-a-combination-of-darolutamide-and-androgen-deprivation-therapy-adt-works-as-a-treatment-before-55147https://curecurrent.com/trials/validation-of-fusion-cemep-score-for-omitting-systematic-prostate-biopsy-55148https://curecurrent.com/trials/bipolar-androgen-therapy-to-restore-sensitivity-to-androgen-deprivation-therapy-for-patients-with-metastatic-castration-55149https://curecurrent.com/trials/prostate-cancer-ire-study-pris-55150https://curecurrent.com/trials/a-study-of-abiraterone-acetate-plus-prednisone-with-or-without-abemaciclib-ly2835219-in-participants-with-prostate-cance-55151https://curecurrent.com/trials/effects-of-exercise-prior-to-radical-prostatectomy-55152https://curecurrent.com/trials/a-study-of-dm002-in-patients-with-advanced-solid-tumors-55153https://curecurrent.com/trials/prospective-database-of-clinical-outcomes-following-cryotherapy-for-ablation-of-clinically-localized-prostate-cancer-55154https://curecurrent.com/trials/validation-of-a-platelet-proteomic-assay-for-diagnosing-and-monitoring-prostate-cancer-55155https://curecurrent.com/trials/vorinostat-and-177lu-psma-617-for-the-treatment-of-psma-low-metastatic-castration-resistant-prostate-cancer-55156https://curecurrent.com/trials/collecting-and-studying-blood-and-tissue-samples-from-patients-with-locally-recurrent-or-metastatic-prostate-or-bladder-55157https://curecurrent.com/trials/a-study-in-which-non-metastatic-castration-resistant-prostate-cancer-nmcrpc-patients-for-whom-a-decision-to-treat-with-d-55158https://curecurrent.com/trials/single-port-transvesical-partial-prostatectomy-versus-high-intensity-focused-ultrasound-55159https://curecurrent.com/trials/assessing-efficacy-of-neoadjuvant-adt-in-localized-high-risk-prostate-cancer-patients-utilizing-18f-flotufolastat-psma-p-55160https://curecurrent.com/trials/comparison-of-new-surecore-biopsy-of-needle-to-standard-of-care-during-transperineal-prostate-biopsies-55161https://curecurrent.com/trials/68ga-psma-11-pet-mri-for-selecting-men-with-prostate-cancer-for-focal-therapy-55162https://curecurrent.com/trials/nerve-sparing-robotic-prostatectomy-the-impact-of-patient-baseline-profiles-on-erectile-function-55163https://curecurrent.com/trials/prostate-specific-membrane-antigen-psma-pet-scans-in-people-prostate-cancer-55164https://curecurrent.com/trials/safety-and-efficacy-of-kls-1-monotherapy-in-malignant-neoplasms-55165https://curecurrent.com/trials/a-trial-comparing-docetaxel-75-mg-m2-3w-versus-docetaxel-50-mg-m2-2w-in-combination-with-darolutamide-adt-in-mhspc-patie-55166https://curecurrent.com/trials/water-iv-pca-as-sub-study-55167https://curecurrent.com/trials/phase-3-multicenter-randomized-study-evaluating-the-efficacy-and-tolerability-of-focused-hifu-high-intensity-focused-ult-55168https://curecurrent.com/trials/effect-of-education-to-be-provided-to-patients-to-undergo-turp-with-mobile-application-on-patient-outcomes-55169https://curecurrent.com/trials/strategic-endocrine-therapy-and-targeted-radiotherapy-for-prostate-cancer-55170https://curecurrent.com/trials/prostate-specific-membrane-antigen-psma-radionuclide-therapy-55171https://curecurrent.com/trials/patient-and-provider-perspectives-on-genetic-risk-profiling-55172https://curecurrent.com/trials/brain-and-pelvic-floor-muscle-activity-of-patients-who-had-or-are-undergoing-robot-assisted-radical-prostatectomy-55173https://curecurrent.com/trials/effect-of-rectus-block-timing-on-opioid-use-55174https://curecurrent.com/trials/propranolol-hydrochloride-in-treating-patients-with-prostate-cancer-undergoing-surgery-55175https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-darolutamide-and-stereotactic-dose-escalated-radiotherapy-in-patients-with-l-55176https://curecurrent.com/trials/radiotherapy-to-the-prostate-and-dominant-intra-prostatic-lesion-dil-55177https://curecurrent.com/trials/testing-two-oral-drugs-combination-cediranib-and-olaparib-compared-to-a-single-drug-olaparib-for-men-with-advanced-prost-55178https://curecurrent.com/trials/testing-the-effect-of-m1774-on-hard-to-treat-refractory-spop-mutant-prostate-cancer-55179https://curecurrent.com/trials/evaluation-of-neoadjuvant-xaluritamig-in-localized-prostate-cancer-55180https://curecurrent.com/trials/radiation-therapy-in-treating-patients-receiving-hormone-therapy-for-prostate-cancer-getug-afu-18-55181https://curecurrent.com/trials/m6620-and-carboplatin-with-or-without-docetaxel-in-treating-patients-with-metastatic-castration-resistant-prostate-cance-55182https://curecurrent.com/trials/a-study-for-the-participants-with-metastatic-hormone-sensitive-prostate-cancer-mhspc-treated-with-androgen-deprivation-t-55183https://curecurrent.com/trials/68ga-rm2-compared-to-68ga-psma-617-pet-ct-for-intermediate-risk-prostate-cancer-imaging-55184https://curecurrent.com/trials/spaceoar-post-market-registry-study-55185https://curecurrent.com/trials/plasma-exosome-rna-to-diagnose-prostate-cancer-55186https://curecurrent.com/trials/phase-ii-study-to-evaluate-the-safety-and-efficacy-of-prostatic-artery-embolization-55187https://curecurrent.com/trials/a-study-of-apalutamide-in-chinese-participants-with-non-metastatic-castration-resistant-prostate-cancer-nm-crpc-55188https://curecurrent.com/trials/micro-ultrasound-guided-prostate-sbrt-55189https://curecurrent.com/trials/clinical-outcomes-in-prostate-cancer-patients-undergoing-hifu-ablation-55190https://curecurrent.com/trials/adaptive-radiation-therapy-art-stereotactic-ablative-body-radiotherapy-sabr-for-primary-localized-prostate-cancer-55191https://curecurrent.com/trials/recoverpc-relugolix-vs-gnrh-agonist-in-quality-of-life-55192https://curecurrent.com/trials/a-study-on-the-effects-of-exercise-therapy-on-signs-of-prostate-cancer-55193https://curecurrent.com/trials/radiation-therapy-and-irreversible-electroporation-for-intermediate-risk-prostate-cancer-rtire-55194https://curecurrent.com/trials/prostate-cancer-risk-calculator-for-actionable-clinical-decision-making-in-nigeria-55195https://curecurrent.com/trials/saruparib-azd5305-vs-placebo-in-men-with-metastatic-castration-sensitive-prostate-cancer-receiving-physician-s-choice-ne-55196https://curecurrent.com/trials/androgen-deprivation-therapy-prior-to-prostatectomy-for-patients-with-intermediate-and-high-risk-prostate-cancer-55197https://curecurrent.com/trials/emindexcare-for-prostate-cancer-patients-undergoing-active-treatment-55198https://curecurrent.com/trials/exercise-to-enhance-cardiovascular-health-among-black-prostate-cancer-patients-with-androgen-deprivation-therapy-55199https://curecurrent.com/trials/metformin-in-patients-initiating-adt-as-prevention-and-intervention-of-metabolic-syndrome-55200https://curecurrent.com/trials/bespoke-decision-support-for-patients-with-newly-diagnosed-localised-prostate-cancer-55201https://curecurrent.com/trials/a-trial-of-androgen-deprivation-docetaxel-and-enzalutamide-for-metastatic-prostate-cancer-55202https://curecurrent.com/trials/testing-the-addition-of-darolutamide-to-hormonal-therapy-androgen-deprivation-therapy-adt-after-surgery-for-men-with-hig-55203https://curecurrent.com/trials/efficacy-and-safety-of-darolutamide-combined-with-docetaxel-and-adt-as-neoadjuvant-therapy-for-locally-advanced-prostate-55204https://curecurrent.com/trials/clinical-trial-of-targeted-alpha-therapy-using-at-211-psma-5-for-prostate-cancer-55205https://curecurrent.com/trials/study-of-xnw5004-tablets-in-advanced-prostate-cancer-55206https://curecurrent.com/trials/photon-counting-computed-tomography-based-urethral-visualization-without-catheterization-for-radiotherapy-planning-a-pro-55207https://curecurrent.com/trials/spect-ct-imaging-for-dosimetry-in-177lu-psma-617-pluvicto-therapy-55208https://curecurrent.com/trials/preoperative-semaglutide-prior-to-radical-prostatectomy-55209https://curecurrent.com/trials/duration-of-androgen-receptor-pathway-inhibitor-and-adt-with-metastasis-directed-therapy-in-oligometastatic-cancer-of-th-55210https://curecurrent.com/trials/the-effectiveness-of-telemedicine-monitoring-prehabilitation-in-prostate-cancer-patients-undergoing-radical-prostatectom-55211https://curecurrent.com/trials/therapeutic-effect-of-cytoreductive-radical-prostatectomy-in-men-with-newly-diagnosed-metastatic-prostate-cancer-55212https://curecurrent.com/trials/surface-electrical-stimulation-for-urinary-incontinence-in-men-treated-for-prostate-cancer-55213https://curecurrent.com/trials/validation-of-claritydx-prostate-as-a-reflex-test-to-refine-the-prediction-of-clinically-significant-prostate-cancer-55214https://curecurrent.com/trials/impact-of-anterior-urethral-suspension-combined-with-pelvic-fascia-reconstruction-during-robot-assisted-radical-prostate-55215https://curecurrent.com/trials/rehabilitation-intervention-to-prevent-adverse-events-related-to-androgen-deprivation-therapy-adt-in-patients-with-metas-55216https://curecurrent.com/trials/contribution-of-the-veriton-ct-camera-in-prostate-bone-radiostereotaxy-55217https://curecurrent.com/trials/trial-of-neoadjuvant-enoblituzumab-vs-soc-in-men-with-high-risk-localized-prostate-cancer-55218https://curecurrent.com/trials/use-of-tracking-devices-to-locate-abnormalities-during-invasive-procedures-55219https://curecurrent.com/trials/abemaciclib-before-177lu-psma-617-for-the-treatment-of-metastatic-castrate-resistant-prostate-cancer-55220https://curecurrent.com/trials/adjuvant-rezvilutamide-monotherapy-for-high-risk-prostate-cancer-after-radical-prostatectomy-55221https://curecurrent.com/trials/nivolumab-combined-with-ipilimumab-for-patients-with-advanced-rare-genitourinary-tumors-55222https://curecurrent.com/trials/application-of-a-novel-model-based-on-plasma-cfdna-assay-and-mrl-imaging-in-the-detection-of-prostate-cancer-55223https://curecurrent.com/trials/comparative-study-of-radiotherapy-treatments-to-treat-high-risk-prostate-cancer-patients-55224https://curecurrent.com/trials/development-of-an-ai-agent-for-urological-disease-diagnosis-and-treatment-55225https://curecurrent.com/trials/18f-fluorthanatrace-positron-emission-tomography-ftt-pet-and-ctdna-to-predict-response-to-parp-inhibitor-therapy-in-meta-55226https://curecurrent.com/trials/resistance-exercise-il-7-and-immune-phenotypes-in-prostate-cancer-55227https://curecurrent.com/trials/imaging-of-solid-tumors-using-18f-trx-55228https://curecurrent.com/trials/clinical-study-of-safety-and-efficacy-of-universal-psma-car-t-in-refractory-crpc-55229https://curecurrent.com/trials/psma-pet-combined-with-mri-for-the-detection-of-pca-55230https://curecurrent.com/trials/observing-the-real-world-non-interventional-study-of-abiraterone-acetate-tablets-ii-in-treating-chinese-patients-with-me-55231https://curecurrent.com/trials/clinical-study-of-safety-and-efficacy-of-enhanced-psma-car-t-in-refractory-crpc-55232https://curecurrent.com/trials/a-study-of-bl-b01d1-combination-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-55233https://curecurrent.com/trials/neurovascular-bundle-stimulation-during-robot-assisted-radical-prostatectomy-55234https://curecurrent.com/trials/zen-3694-enzalutamide-and-pembrolizumab-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-55235https://curecurrent.com/trials/extraperitoneal-single-port-robotic-assisted-radical-prostatectomy-rarp-versus-transperitoneal-multi-port-rarp-in-the-tr-55236https://curecurrent.com/trials/a-study-to-determine-the-preferred-dose-of-the-drug-lisinopril-for-preventing-urinary-toxicity-following-radiotherapy-fo-55237https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-anti-igf-1r-monoclonal-antibody-combined-with-anti-pd-1-monoclonal-antibody-in-treatme-55238https://curecurrent.com/trials/the-application-of-multimodal-artificial-intelligence-systems-in-prostate-cancer-diagnosis-and-prognosis-analysis-55239https://curecurrent.com/trials/pluvicto-real-world-investigation-in-survival-in-metastatic-crpc-55240https://curecurrent.com/trials/salvage-oligometastasectomy-and-radiation-therapy-in-recurrent-prostate-cancer-55241https://curecurrent.com/trials/high-resolution-18f-psma-pet-mri-before-prostate-cancer-hifu-or-radical-prostatectomy-55242https://curecurrent.com/trials/gene-therapy-and-radioactive-iodine-in-treating-patients-with-locally-recurrent-prostate-cancer-that-did-not-respond-to-55243https://curecurrent.com/trials/cjnj-67652000-and-prednisone-for-treatment-of-metastatic-castration-resistant-prostate-cancer-and-spop-gene-mutations-55244https://curecurrent.com/trials/telmisartan-in-prostate-cancer-55245https://curecurrent.com/trials/mild-hypofractionation-with-proton-therapy-or-imrt-for-intermediate-risk-prostate-cancer-55246https://curecurrent.com/trials/archery-artificial-intelligence-based-radiotherapy-treatment-planning-for-cervical-head-and-neck-and-prostate-cancer-55247https://curecurrent.com/trials/prostate-iq-parallel-randomized-study-of-personalized-apalutamide-treatment-and-evaluation-to-improve-quality-of-life-in-55248https://curecurrent.com/trials/clinical-utility-of-claritydx-prostate-55249https://curecurrent.com/trials/mri-guided-transurethral-urethral-ultrasound-ablation-for-the-treatment-of-low-to-intermediate-grade-prostate-cancer-55250https://curecurrent.com/trials/testosterone-replacement-therapy-in-hypogonadal-patients-with-prostate-cancer-under-active-surveillance-55251https://curecurrent.com/trials/low-count-quantitative-spect-for-men-treated-with-radium-223-55252https://curecurrent.com/trials/supraphysiological-androgen-to-enhance-treatment-activity-in-metastatic-castration-resistant-prostate-cancer-spectra-stu-55253https://curecurrent.com/trials/genetic-information-to-inform-treatment-and-screening-for-prostate-cancer-gifts-study-55254https://curecurrent.com/trials/redi-cap-recovery-of-erectile-dysfunction-induced-in-prostate-cancer-patients-55255https://curecurrent.com/trials/fractionated-stereotactic-radiotherapy-plus-second-generation-antiandrogen-for-oligometastatic-castration-resistant-pros-55256https://curecurrent.com/trials/pro-boost-lc-whole-gland-boost-strategies-versus-sbrt-monotherapy-in-psma-staged-localized-and-locally-advanced-prostate-55257https://curecurrent.com/trials/a-study-of-telemedicine-shared-medical-appointments-smas-versus-individual-telemedicine-visits-for-people-with-prostate-55258https://curecurrent.com/trials/large-language-model-assisted-ctnm-annotation-from-chinese-psma-pet-ct-reports-55259https://curecurrent.com/trials/the-study-of-177lu-tlx591-plus-soc-versus-soc-alone-in-patients-with-mcrpc-prostact-global-55260https://curecurrent.com/trials/pro-boost-n-prostate-first-versus-combined-prostate-and-nodal-dose-escalation-in-psma-pet-staged-node-positive-prostate-55261https://curecurrent.com/trials/multi-parametric-ultrasound-versus-multi-parametric-mri-for-prostate-cancer-detection-55262https://curecurrent.com/trials/radium-223-for-high-volume-metastatic-hormone-sensitive-prostate-cancer-55263https://curecurrent.com/trials/gadopiclenol-in-contrast-enhanced-mri-of-the-prostate-55264https://curecurrent.com/trials/stereotactic-body-radiation-therapy-plus-immediate-or-delayed-androgen-receptor-pathway-inhibitor-and-androgen-deprivati-55265https://curecurrent.com/trials/jump-mr-simulation-for-radiation-therapy-master-protocol-55266https://curecurrent.com/trials/flibanserin-in-men-receiving-androgen-suppression-for-prostate-cancer-55267https://curecurrent.com/trials/mri-dti-assessment-of-urethral-internal-sphincter-ring-and-prostate-base-morphology-55268https://curecurrent.com/trials/sequential-testosterone-and-enzalutamide-prevents-unfavorable-progression-55269https://curecurrent.com/trials/psma-pet-registry-for-recurrent-prostate-cancer-55270https://curecurrent.com/trials/transperineal-versus-transrectal-cognitive-fusion-prostate-biopsy-55271https://curecurrent.com/trials/saruparib-in-combination-with-physician-s-choice-of-arpi-in-patients-with-mhspc-previously-treated-with-docetaxel-or-177-55272https://curecurrent.com/trials/99mtc-psma-i-s-biodistribution-in-patients-with-prostate-cancer-55273https://curecurrent.com/trials/extremely-hypofractionated-intensity-modulated-stereotactic-body-radiotherapy-for-the-treatment-of-prostate-cancer-with-55274https://curecurrent.com/trials/hormone-therapy-apalutamide-and-image-guided-stereotactic-body-radiation-therapy-for-the-treatment-of-patients-with-pros-55275https://curecurrent.com/trials/improving-quality-of-life-of-prostate-cancer-survivors-with-androgen-deficiency-55276https://curecurrent.com/trials/diet-and-exercise-interventions-among-men-with-prostate-cancer-prostate-8-ii-55277https://curecurrent.com/trials/targeted-biopsy-rapid-pathology-and-immediate-surgery-in-ustc-high-risk-prostate-cancer-a-prospective-multicenter-study-55278https://curecurrent.com/trials/assessing-financial-toxicity-using-the-proffit-questionnaire-in-patients-treated-with-mini-invasive-approach-for-urologi-55279https://curecurrent.com/trials/radioactive-counts-from-psma-pet-ct-targeted-biopsy-specimens-for-real-time-diagnosis-of-prostate-cancer-a-prospective-s-55280https://curecurrent.com/trials/a-study-of-real-world-characteristics-treatment-patterns-and-outcomes-among-mcrpc-patients-previously-treated-with-an-an-55281https://curecurrent.com/trials/terbinafine-for-biochemically-recurrent-prostate-cancer-terbinapro-55282https://curecurrent.com/trials/a-study-of-real-world-characteristics-treatment-patterns-and-clinical-outcomes-in-patients-with-metastatic-castration-re-55283https://curecurrent.com/trials/neoadjuvant-theranostic-lutetium-study-the-nautilus-trial-55284https://curecurrent.com/trials/exercise-for-tumor-suppressive-impact-in-men-with-prostate-cancer-at-high-risk-of-progression-on-active-surveillance-the-55285https://curecurrent.com/trials/advanced-chemohormonal-therapy-for-treatment-naive-metastatic-prostate-cancer-55286https://curecurrent.com/trials/utility-of-hyperpolarized-13c-pyruvate-metabolic-magnetic-resonance-imaging-55287https://curecurrent.com/trials/pilot-feasibility-study-of-a-dyadic-culinary-nutrition-intervention-55288https://curecurrent.com/trials/diffusion-basis-spectrum-imaging-of-the-prostate-55289https://curecurrent.com/trials/docetaxel-to-androgen-receptor-pathway-inhibitors-in-patients-with-metastatic-castration-sensitive-prostate-cancer-and-s-55290https://curecurrent.com/trials/pembro-with-radiation-with-or-without-olaparib-55291https://curecurrent.com/trials/an-investigational-scan-18f-rhpsma-7-3-pet-mpmri-for-targeted-prostate-biopsy-using-trus-mr-fusion-technique-55292https://curecurrent.com/trials/human-amnion-membrane-allograft-and-early-return-of-erectile-function-after-radical-prostatectomy-55293https://curecurrent.com/trials/a-study-of-stereotactic-body-radiation-therapy-sbrt-without-androgen-deprivation-therapy-adt-in-people-with-unfavorable-55294https://curecurrent.com/trials/evaluation-of-pelvic-floor-function-and-psychosocial-sequelae-following-radical-prostatectomy-for-prostate-cancer-55295https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-combination-therapies-in-metastatic-castration-resistant-prostate-cancer-mk-3475-365-keyn-55296https://curecurrent.com/trials/aberrant-gene-expression-prostate-carcinoma-55297https://curecurrent.com/trials/massage-for-prostate-cancer-related-fatigue-mprostate-55298https://curecurrent.com/trials/a-multi-center-prospective-observational-study-of-patients-being-treated-with-orgovyx-55299https://curecurrent.com/trials/intrapatient-comparison-of-urinary-radioactivity-following-piflufolastat-18f-and-flotufolastat-18f-pet-in-men-with-low-p-55300https://curecurrent.com/trials/real-world-experience-with-lutetium-vipivotide-tetraxetan-in-metastatic-castration-resistant-prostate-cancer-55301https://curecurrent.com/trials/holep-prior-to-radiation-therapy-for-patients-with-luts-retention-and-concurrent-prostate-cancer-55302https://curecurrent.com/trials/prospective-study-of-ultrahypofractionated-proton-beam-therapy-for-localized-prostate-cancer-55303https://curecurrent.com/trials/focal-radiation-with-pulsed-systemic-therapy-of-abiraterone-androgen-deprivation-therapy-adt-lynparza-towards-castration-55304https://curecurrent.com/trials/study-of-lutetium-177lu-vipivotide-tetraxetan-in-mcrpc-participants-with-moderately-and-severely-impaired-and-with-norma-55305https://curecurrent.com/trials/men-moving-forward-a-lifestyle-program-for-african-american-prostate-cancer-survivors-55306https://curecurrent.com/trials/study-of-neoadjuvant-parp-inhibition-followed-by-radical-prostatectomy-in-patients-with-unfavorable-intermediate-risk-or-55307https://curecurrent.com/trials/stem-cells-for-erectile-dysfunction-post-ralp-55308https://curecurrent.com/trials/testing-the-addition-of-a-new-anti-cancer-drug-niraparib-to-the-usual-treatment-hormone-and-radiation-therapy-for-prosta-55309https://curecurrent.com/trials/trial-evaluating-the-safety-and-efficacy-of-mr-linac-guided-radiotherapy-as-salvage-treatment-after-external-beam-radiot-55310https://curecurrent.com/trials/study-of-how-people-make-decisions-about-prostate-cancer-risk-55311https://curecurrent.com/trials/hypofractionated-radiation-therapy-or-conventional-radiation-therapy-after-surgery-in-treating-patients-with-prostate-ca-55312https://curecurrent.com/trials/improving-cryoablation-efficacy-with-barrigel-rectal-spacing-ice-barr-55313https://curecurrent.com/trials/a-clinical-study-of-ktx-2001-in-subjects-with-metastatic-castration-resistant-prostate-cancer-strike-001-55314https://curecurrent.com/trials/efficacy-and-safety-of-simultaneous-integrated-boost-radiotherapy-in-hr-vhr-prostate-cancer-with-eplni-55315https://curecurrent.com/trials/study-of-oric-944-in-patients-with-metastatic-prostate-cancer-55316https://curecurrent.com/trials/hypofractionated-stereotactic-body-radiation-therapy-as-a-boost-to-the-prostate-55317https://curecurrent.com/trials/safety-and-efficacy-study-of-enzalutamide-plus-leuprolide-in-patients-with-nonmetastatic-prostate-cancer-embark-55318https://curecurrent.com/trials/a-trial-to-find-out-if-regn5678-nezastomig-is-safe-and-how-well-it-works-alone-or-in-combination-with-cemiplimab-for-adu-55319https://curecurrent.com/trials/a-clinical-study-of-68ga-ga-eli421-injection-pet-imaging-in-patients-with-prostate-cancer-55320https://curecurrent.com/trials/drug-intensive-monitoring-study-of-olaparib-in-clinical-practice-among-chinese-patients-55321https://curecurrent.com/trials/robotic-prostatectomy-artificial-intelligence-low-pressure-pain-ralp-trial-55322https://curecurrent.com/trials/infrared-fluorescence-staining-versus-frozen-section-for-prostate-cancer-surgery-55323https://curecurrent.com/trials/social-structural-and-lifestyle-drivers-of-prostate-cancer-disparities-55324https://curecurrent.com/trials/a-study-to-learn-about-real-world-utilization-and-outcomes-of-darolutamide-and-other-androgen-receptor-pathway-inhibitor-55325https://curecurrent.com/trials/stereotactic-body-radiotherapy-or-standard-of-care-for-prostate-oligoprogressive-cancer-55326https://curecurrent.com/trials/germline-dna-based-radiosensitivity-biomarker-influence-on-toxicity-following-prostate-radiotherapy-garuda-trial-55327https://curecurrent.com/trials/a-study-to-learn-how-men-with-advanced-prostate-cancer-respond-to-treatment-with-darolutamide-and-hormone-therapy-with-o-55328https://curecurrent.com/trials/a-study-to-compare-darolutamide-given-with-androgen-deprivation-therapy-adt-and-placebo-given-with-adt-in-men-with-hormo-55329https://curecurrent.com/trials/bortezomib-in-patients-with-metastatic-castration-resistant-prostate-cancer-with-pten-deletion-55330https://curecurrent.com/trials/integrating-quantitative-mri-and-artificial-intelligence-to-improve-prostate-cancer-classification-55331https://curecurrent.com/trials/low-psma-suv-boost-lps-boost-intensified-177lu-psma-617-treatment-for-patients-with-metastatic-castrate-resistant-prosta-55332https://curecurrent.com/trials/first-in-human-study-of-225ac-psma-trillium-bay-3563254-in-participants-with-advanced-metastatic-castration-resistant-pr-55333https://curecurrent.com/trials/prostate-specific-membrane-antigen-psma-or-facbc-pet-ct-site-directed-therapy-for-treatment-of-prostate-cancer-flu-blast-55334https://curecurrent.com/trials/ai-llm-communication-aid-in-prostate-cancer-care-ai-cap-55335https://curecurrent.com/trials/adoptive-transfer-of-autologous-t-cells-targeted-to-prostate-specific-membrane-antigen-psma-for-the-treatment-of-castrat-55336https://curecurrent.com/trials/radiant-a-study-of-radium-223-dichloride-xofigo-vs-enzalutamide-or-abiraterone-arpis-androgen-receptor-pathway-inhibitor-55337https://curecurrent.com/trials/prostate-radiotherapy-and-metastasis-directed-therapy-in-synchronous-oligometastatic-prostate-cancer-55338https://curecurrent.com/trials/a-study-to-learn-more-about-how-safe-darolutamide-is-and-how-well-it-works-under-real-world-conditions-when-taken-in-add-55339https://curecurrent.com/trials/feasibility-of-mr-informed-adaptive-marker-less-sbrt-in-patients-with-bilateral-hip-prostheses-undergoing-sbrt-for-local-55340https://curecurrent.com/trials/68ga-p16-093-pet-imaging-for-diagnosing-prostate-cancer-a-head-to-head-comparison-with-mpmri-55341https://curecurrent.com/trials/a-study-of-jnj-78278343-a-t-cell-redirecting-agent-targeting-human-kallikrein-2-klk2-for-advanced-prostate-cancer-55342https://curecurrent.com/trials/combining-ipilimumab-degarelix-and-radical-prostatectomy-in-men-with-newly-diagnosed-metastatic-castration-sensitive-pro-55343https://curecurrent.com/trials/diagnostic-performance-of-18f-psma-1007-pet-ct-in-suspected-prostate-cancer-patient-55344https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-cp-pca07-in-combination-with-enzalutamide-in-patients-with-castration-resistant-pros-55345https://curecurrent.com/trials/inspire-innovative-sabr-for-prostate-cancer-all-ireland-55346https://curecurrent.com/trials/online-adaptive-stereotactic-body-radiotherapy-for-localized-prostate-cancer-55347https://curecurrent.com/trials/an-observational-study-to-learn-more-about-how-medicines-that-block-male-hormones-are-used-in-people-with-prostate-cance-55348https://curecurrent.com/trials/predictors-of-bcr-after-rarp-for-localized-prostate-cancer-a-retrospective-analysis-55349https://curecurrent.com/trials/post-marketing-study-on-pluvicto-in-korea-55350https://curecurrent.com/trials/intraprostatic-anesthesia-during-transperineal-prostate-biopsy-55351https://curecurrent.com/trials/escalating-cycle-1-dose-of-lu-177-psma-617-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-55352https://curecurrent.com/trials/decision-making-in-men-with-early-stage-prostate-cancer-patients-and-partners-close-allies-55353https://curecurrent.com/trials/long-acting-lhrh-versus-short-acting-lhrh-in-the-treatment-of-prostate-cancer-55354https://curecurrent.com/trials/rhpsma-73-pet-mri-imaging-for-the-detection-of-prostate-cancer-among-men-who-are-otherwise-candidates-for-active-surveil-55355https://curecurrent.com/trials/adaptive-stereotactic-body-radiation-therapy-to-the-prostate-and-pelvic-nodes-with-simultaneous-integrated-boost-to-the-55356https://curecurrent.com/trials/effects-of-combined-training-in-prostate-cancer-patients-55357https://curecurrent.com/trials/an-investigational-scan-rhpsma-7-3-pet-ct-for-detecting-biochemically-recurrent-prostate-cancer-enlighten-trial-55358https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-efficacy-of-xaluritamig-in-combination-with-androgen-receptor-pathway-inhib-55359https://curecurrent.com/trials/a-study-for-cardiovascular-and-lifestyle-risk-factors-in-prostate-cancer-patients-55360https://curecurrent.com/trials/high-dose-brachytherapy-in-treating-patients-with-prostate-cancer-55361https://curecurrent.com/trials/medico-economic-evaluation-of-imrt-by-hi-art-rapidarc-vmat-therapy-in-prostate-cervix-and-anal-canal-cancers-55362https://curecurrent.com/trials/177lu-psma-617-combined-with-darolutamide-in-neoadjuvant-treatment-of-high-risk-localized-prostate-cancer-a-prospective-55363https://curecurrent.com/trials/total-en-bloc-urethra-preservation-at-robot-assisted-prostatectomy-ideal-stage-2a-55364https://curecurrent.com/trials/non-inferiority-study-comparing-salvage-pelvic-radiotherapy-in-25-fractions-62-5-gy-25-versus-20-fractions-52-5-gy-20-fo-55365https://curecurrent.com/trials/sexual-health-communication-skills-training-intervention-for-patients-with-prostate-cancer-55366https://curecurrent.com/trials/darolutamide-in-metastatic-castration-resistant-prostate-cancer-mcrpc-55367https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-with-abiraterone-in-men-with-prostate-cancer-that-has-spread-to-other-parts-of-the-body-55368https://curecurrent.com/trials/7-days-water-only-fasting-or-ketone-supplementation-trial-in-prostate-cancer-55369https://curecurrent.com/trials/prostate-mri-analysis-by-radiologists-and-artificial-intelligence-disease-identification-and-guided-management-55370https://curecurrent.com/trials/neoadjuvant-sglt2-inhibition-in-localized-prostate-cancer-55371https://curecurrent.com/trials/locally-ablative-therapy-in-oligo-progressive-genitourinary-tumors-layover-55372https://curecurrent.com/trials/a-study-to-investigate-the-biological-effects-of-saruparib-azd5305-darolutamide-and-in-combination-in-men-with-newly-dia-55373https://curecurrent.com/trials/focal-ablation-with-focal-cryotherapy-or-hifu-for-the-treatment-of-men-with-localized-prostate-cancer-55374https://curecurrent.com/trials/phase-ii-trial-of-psa-response-based-androgen-deprivation-therapy-and-nodal-coverage-for-prostate-cancer-early-salvage-r-55375https://curecurrent.com/trials/investigation-into-detection-of-prostate-cancer-using-voided-urine-prostate-vpac-55376https://curecurrent.com/trials/darolutamide-androgen-deprivation-therapy-adt-in-chinese-men-with-high-risk-nonmetastatic-prostate-cancer-55377https://curecurrent.com/trials/evaluating-fluciclovine-pet-in-patients-with-biochemical-recurrence-of-prostate-cancer-and-a-negative-psma-pet-55378https://curecurrent.com/trials/comparison-of-hdr-vs-ldr-brachytherapy-as-monotherapy-for-intermediate-risk-prostate-cancer-55379https://curecurrent.com/trials/prolong-prostateolapariboncombinationgcc-study-55380https://curecurrent.com/trials/whole-versus-partial-gland-boost-during-prostate-sbrt-55381https://curecurrent.com/trials/xl092-in-patients-with-metastatic-castration-resistant-prostate-cancer-55382https://curecurrent.com/trials/partial-prostate-salvage-high-dose-rate-brachytherapy-55383https://curecurrent.com/trials/ftt-pet-ct-in-metastatic-prostate-cancer-55384https://curecurrent.com/trials/intermittent-androgen-deprivation-therapy-with-or-without-stereotactic-body-radiotherapy-for-molecularly-identified-horm-55385https://curecurrent.com/trials/efforts-to-increase-representation-in-prostate-cancer-clinical-trials-at-lyndon-b-johnson-hospital-55386https://curecurrent.com/trials/treatment-approaches-and-biomarkers-prevalence-in-de-novo-metastatic-hormone-sensitive-prostate-cancer-in-russian-federa-55387https://curecurrent.com/trials/abemaciclib-plus-darolutamide-in-prostate-cancer-that-has-spread-after-initial-treatment-55388https://curecurrent.com/trials/the-effects-of-castration-on-the-pharmacokinetics-of-zolpidem-after-single-dose-administration-in-men-with-prostate-canc-55389https://curecurrent.com/trials/clinical-evaluation-of-177lu-lu-bq7876-for-targeting-of-prostate-specific-membrane-antigen-55390https://curecurrent.com/trials/a-study-to-learn-about-heart-related-risks-in-elderly-men-with-advanced-prostate-cancer-treated-with-enzalutamide-or-dar-55391https://curecurrent.com/trials/coq10-and-vitamin-e-for-off-target-radiation-toxicity-55392https://curecurrent.com/trials/the-impact-of-a-web-based-empowerment-program-on-intolerance-of-uncertainty-and-maintenance-burden-55393https://curecurrent.com/trials/rectal-spacers-in-prostate-cancer-patients-undergoing-radiation-therapy-55394https://curecurrent.com/trials/phenelzine-sulfate-in-treating-patients-with-non-metastatic-recurrent-prostate-cancer-55395https://curecurrent.com/trials/testing-the-effects-of-low-dose-apalutamide-on-prostate-specific-antigen-psa-levels-in-men-scheduled-for-removal-of-the-55396https://curecurrent.com/trials/a-study-of-tinengotinib-tt-00420-in-combination-with-standard-treatments-in-people-with-prostate-cancer-55397https://curecurrent.com/trials/comparison-of-changes-in-tumor-burden-in-68ga-psma-11-pet-ct-and-177lu-psma-spect-ct-in-metastatic-castration-resistant-55398https://curecurrent.com/trials/a-study-of-stereotactic-body-radiotherapy-and-177lu-psma-617-for-the-treatment-of-prostate-cancer-55399https://curecurrent.com/trials/bicalutamide-with-or-without-akt-inhibitor-mk2206-in-treating-patients-with-previously-treated-prostate-cancer-55400https://curecurrent.com/trials/phase-ii-randomized-trial-of-2-versus-5-fraction-prostate-stereotactic-ablative-radiotherapy-for-intermediate-risk-prost-55401https://curecurrent.com/trials/infective-complications-in-tp-biopsy-without-antibiotic-prophylaxis-55402https://curecurrent.com/trials/a-safety-and-efficacy-study-of-enzalutamide-in-indian-patients-with-progressive-metastatic-castration-resistant-prostate-55403https://curecurrent.com/trials/gemcitabine-hydrochloride-and-cisplatin-with-or-without-bevacizumab-in-treating-patients-with-advanced-urinary-tract-can-55404https://curecurrent.com/trials/molecular-imaging-of-prostate-specific-membrane-antigen-using-labeled-technetium-99m-bq0413-55405https://curecurrent.com/trials/evaluation-of-late-toxicity-following-intensity-modulated-radiotherapy-and-two-image-guided-strategies-with-correspondin-55406https://curecurrent.com/trials/magnetic-resonance-imaging-mri-with-hyperpolarized-pyruvate-13c-as-diagnostic-tool-in-advanced-prostate-cancer-55407https://curecurrent.com/trials/relapse-in-previously-irradiated-prostate-bed-stereotactic-ablative-reirradiation-potentiated-by-metformin-55408https://curecurrent.com/trials/prostate-hypoxia-tic-55409https://curecurrent.com/trials/optimal-psa-triggered-individual-management-of-androgen-sensitive-prostate-cancer-55410https://curecurrent.com/trials/targeted-microwave-tissue-coagulation-for-prostate-cancer-55411https://curecurrent.com/trials/artificial-intelligence-ai-enhanced-pretreatment-peer-review-process-to-improve-patient-safety-in-radiation-oncology-55412https://curecurrent.com/trials/advanced-imaging-for-radiotherapy-treatment-planning-and-guidance-for-low-intermediate-risk-prostate-cancer-margin-55413https://curecurrent.com/trials/androgen-ablation-therapy-with-or-without-niraparib-after-radiation-therapy-for-the-treatment-of-high-risk-localized-or-55414https://curecurrent.com/trials/a-study-of-sync-t-therapy-sv-102-in-participants-with-metastatic-castration-resistant-prostate-cancer-55415https://curecurrent.com/trials/stockholm3-test-validation-in-men-on-active-surveillance-in-switzerland-chas3-trial-55416https://curecurrent.com/trials/tumor-target-prostate-cancer-55417https://curecurrent.com/trials/ai-based-prediction-of-prostate-cancer-metastasis-using-biopsy-pathology-55418https://curecurrent.com/trials/ai-multimodal-model-for-predicting-crpc-progression-risk-55419https://curecurrent.com/trials/enzalutamide-with-lu-psma-617-versus-enzalutamide-alone-in-men-with-metastatic-castration-resistant-prostate-cancer-55420https://curecurrent.com/trials/early-detection-of-prostate-cancer-55421https://curecurrent.com/trials/hdr-focal-feasibility-study-55422https://curecurrent.com/trials/detection-of-viable-ctcs-using-the-epidrop-technology-in-metastatic-prostate-cancer-epidrop-55423https://curecurrent.com/trials/high-dose-rate-brachytherapy-55424https://curecurrent.com/trials/clinical-evaluation-of-177lu-psma-vg01-injection-in-patients-with-psma-positive-metastatic-castration-resistant-prostate-55425https://curecurrent.com/trials/impact-on-quality-of-life-3-years-after-diagnosis-of-prostate-cancer-55426https://curecurrent.com/trials/prostate-cancer-subclinical-metastatic-ablative-mr-guided-radiotherapy-55427https://curecurrent.com/trials/a-fih-phase-i-iia-trial-assessing-feasibility-of-administrations-of-til-based-immunotherapy-in-patients-with-metastatic-55428https://curecurrent.com/trials/the-cosmyc-trial-combined-suppression-of-myc-55429https://curecurrent.com/trials/effects-of-direct-artery-injection-on-prostate-cancer-drug-delivery-and-tumor-uptake-imaging-based-prediction-of-treatme-55430https://curecurrent.com/trials/a-study-of-lower-dose-radiation-therapy-for-people-with-prostate-cancer-55431https://curecurrent.com/trials/a-study-to-learn-more-about-how-safe-darolutamide-is-under-real-world-conditions-in-participants-with-metastatic-hormone-55432https://curecurrent.com/trials/dual-tracer-pet-radiomics-for-prostate-cancer-stratification-55433https://curecurrent.com/trials/postoperative-or-salvage-radiotherapy-rt-for-node-negative-prostate-cancer-following-radical-prostatectomy-55434https://curecurrent.com/trials/intelligent-screening-and-precision-diagnosis-of-prostate-cancer-based-on-multimodal-data-55435https://curecurrent.com/trials/a-study-to-assess-adverse-events-and-how-intravenously-iv-infused-abbv-969-moves-through-the-bodies-of-adult-participant-55436https://curecurrent.com/trials/phase-iii-randomized-international-open-label-clinical-trial-of-treatment-intensification-with-docetaxel-plus-apalutamid-55437https://curecurrent.com/trials/leveraging-ea8191-to-assess-ai-augmented-ehr-abstraction-55438https://curecurrent.com/trials/abemaciclib-with-or-without-atezolizumab-for-mcrpc-55439https://curecurrent.com/trials/study-of-olaparib-maintenance-following-cabazitaxel-carbo-in-men-with-avpc-55440https://curecurrent.com/trials/radiotherapy-after-prostatectomy-for-node-positive-prostate-cancer-55441https://curecurrent.com/trials/whole-food-plant-based-diet-to-control-weight-and-metaboinflammation-in-overweight-obese-men-with-prostate-cancer-55442https://curecurrent.com/trials/prostate-cancer-treatment-using-androgen-deprivation-therapy-and-focal-prostate-ablation-55443https://curecurrent.com/trials/alpha-radiation-emitters-device-dart-for-the-treatment-of-non-metastatic-locally-recurrent-prostate-cancer-55444https://curecurrent.com/trials/hypofractionated-proton-beam-therapy-for-localized-prostate-cancer-55445https://curecurrent.com/trials/psma-directed-para-aortic-radiation-therapy-for-oligorecurrent-prostate-cancer-55446https://curecurrent.com/trials/spinal-versus-general-anesthesia-in-open-simple-prostatectomy-55447https://curecurrent.com/trials/neo-dab-darolutamide-and-abemaciclib-in-prostate-cancer-55448https://curecurrent.com/trials/abiraterone-enzalutamide-or-apalutamide-in-castrate-sensitive-prostate-cancer-55449https://curecurrent.com/trials/trial-of-curcumin-to-prevent-progression-of-low-risk-prostate-cancer-under-active-surveillance-55450https://curecurrent.com/trials/water-vapor-ablation-for-localized-intermediate-risk-prostate-cancer-55451https://curecurrent.com/trials/opioid-free-pain-control-regimen-following-robotic-radical-prostatectomy-55452https://curecurrent.com/trials/image-guided-biopsies-to-identify-mechanisms-of-resistance-in-patients-with-metastatic-castration-resistant-prostate-can-55453https://curecurrent.com/trials/mr-guided-single-fraction-sbrt-for-nodal-oligorecurrent-prostate-cancer-pinpoint-55454https://curecurrent.com/trials/risk-factors-incidence-and-progression-of-lymphedema-among-men-with-prostate-cancer-the-aware-cohort-55455https://curecurrent.com/trials/randomized-study-to-evaluate-mace-in-patients-with-prostate-cancer-treated-with-relugolix-or-leuprolide-acetate-55456https://curecurrent.com/trials/research-of-double-positive-circulating-cells-tumor-marker-cd45-in-several-types-of-metastatic-cancers-55457https://curecurrent.com/trials/clinically-actionable-tumor-associated-antigens-in-prostate-cancer-55458https://curecurrent.com/trials/presurgical-phase-ii-study-of-talazoparib-in-combination-with-enzalutamide-in-prostate-cancer-55459https://curecurrent.com/trials/sunitinib-malate-with-hormonal-ablation-for-patients-who-will-have-prostatectomy-55460https://curecurrent.com/trials/targeted-early-detection-program-in-men-at-high-genetic-risk-for-prostate-cancer-55461https://curecurrent.com/trials/clinical-data-collection-of-patients-treated-with-high-intensity-focused-ultrasound-hifu-by-the-focal-one-for-their-pros-55462https://curecurrent.com/trials/patients-with-metastasized-prostate-cancer-whose-prostate-specific-antigen-level-psa-remains-0-2-ng-ml-after-six-months-55463https://curecurrent.com/trials/fosfomycin-for-male-urinary-tract-infection-55464https://curecurrent.com/trials/trimodal-18-f-choline-pet-mpmri-trus-targeted-prostate-biopsies-55465https://curecurrent.com/trials/marker-driven-selection-of-patients-for-prostate-biopsy-and-management-55466https://curecurrent.com/trials/diagnostic-performance-of-psma-pet-ct-for-pre-operative-lymph-node-assessment-in-intermediate-and-high-risk-non-metastas-55467https://curecurrent.com/trials/ultrahypofractionated-adaptive-radiation-therapy-of-prostate-cancer-55468https://curecurrent.com/trials/dual-target-psma-psca-car-nk-cells-in-advanced-prostate-cancer-55469https://curecurrent.com/trials/a-smart-design-to-optimize-the-delivery-of-tempo-for-men-with-prostate-cancer-and-their-caregivers-55470https://curecurrent.com/trials/evaluation-of-perilesional-biopsy-in-diagnosis-of-prostate-cancer-55471https://curecurrent.com/trials/a-pan-canadian-investigator-initiated-clinical-trial-with-focal-ire-directed-to-intermediate-risk-prostate-cancer-55472https://curecurrent.com/trials/phase-2-study-of-ivonescimab-in-patients-with-cutaneous-squamous-cell-carcinoma-55473https://curecurrent.com/trials/optimizing-prostate-biopsy-schemes-in-men-with-multiple-mri-visible-lesions-55474https://curecurrent.com/trials/phase-i-study-of-225ac-j591-plus-177lu-psma-small-molecule-for-progressive-metastatic-castration-resistant-prostate-canc-55475https://curecurrent.com/trials/trial-evaluating-the-efficacy-of-carboplatin-in-metastatic-prostate-cancer-with-gene-alterations-in-the-homologous-recom-55476https://curecurrent.com/trials/creatine-supplementation-and-resistance-training-to-improve-sarcopenia-parameters-in-patients-with-prostate-cancer-after-55477https://curecurrent.com/trials/optimizing-the-number-of-systematic-cores-during-a-mri-target-biopsy-55478https://curecurrent.com/trials/the-use-of-nanoparticles-to-guide-the-surgical-treatment-of-prostate-cancer-55479https://curecurrent.com/trials/clinical-trial-to-observe-the-effects-of-tamoxifen-on-testosterone-recovery-in-medically-castrated-prostate-cancer-patie-55480https://curecurrent.com/trials/breathing-practice-for-brain-and-mental-health-in-cancer-and-neurodegenerative-diseases-55481https://curecurrent.com/trials/68ga-fapi-psma-pet-imaging-for-the-diagnosis-of-solid-tumors-55482https://curecurrent.com/trials/terbium-161-psma-in-lutetium-177-psma-naive-patients-55483https://curecurrent.com/trials/pharmacogenomics-ind-commercial-snp-clinical-study-abiraterone-and-single-nucleotide-polymorphisms-55484https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-and-dosimetry-of-imaging-with-68ga-oncoacp3-in-prostate-cancer-55485https://curecurrent.com/trials/using-fapi-pet-mri-to-evaluate-prostate-cancer-55486https://curecurrent.com/trials/the-effect-of-a-structured-strength-and-endurance-training-program-on-quality-of-life-fitness-blood-parameters-and-survi-55487https://curecurrent.com/trials/aspirin-and-rintatolimod-with-or-without-interferon-alpha-2b-in-treating-patients-with-prostate-cancer-before-surgery-55488https://curecurrent.com/trials/a-phase-2-trial-of-61cu-nu101-pet-ct-compared-against-current-standard-of-care-18f-piflufolastat-pylarify-pet-ct-55489https://curecurrent.com/trials/qlf4113-in-participants-with-metastatic-prostate-cancer-55490https://curecurrent.com/trials/urine-prostate-screening-integrated-with-mri-for-early-detection-of-prostate-cancer-uprise-trial-55491https://curecurrent.com/trials/a-feasibility-study-of-biometric-measurements-via-wearable-smart-watch-technology-for-evaluation-of-vasomotor-symptoms-i-55492https://curecurrent.com/trials/a-study-to-evaluate-hypofractionated-proton-therapy-or-imrt-for-recurrent-oligometastatic-prostate-cancer-55493https://curecurrent.com/trials/combining-high-frequency-micro-ultrasound-and-multiparametric-mri-target-biopsy-for-detecting-prostate-cancer-55494https://curecurrent.com/trials/pertuzumab-trastuzumab-hyaluronidase-zzxf-and-enzalutamide-for-treatment-of-metastatic-castration-resistant-prostate-can-55495https://curecurrent.com/trials/multicohort-phase-ii-trial-of-sephb4-hsa-pembrolizumab-in-solid-tumors-55496https://curecurrent.com/trials/high-intensity-focused-ultrasound-in-prostate-cancer-55497https://curecurrent.com/trials/an-international-prospective-open-label-randomized-phase-iii-study-comparing-177lu-psma-617-in-combination-with-standard-55498https://curecurrent.com/trials/immunological-effects-of-vitamin-d-replacement-among-black-african-american-prostate-cancer-patients-55499https://curecurrent.com/trials/perspectives-about-online-information-55500https://curecurrent.com/trials/electric-cardiometry-guided-standard-versus-restricted-fluid-therapy-in-robotic-prostaectomy-55501https://curecurrent.com/trials/qlc5508-in-participants-with-metastatic-prostate-cancer-55502https://curecurrent.com/trials/prostate-diffusion-imaging-with-distortion-correction-55503https://curecurrent.com/trials/feasibility-of-day-surgery-management-for-patients-undergoing-robotic-radical-prostatectomy-a-randomized-trial-55504https://curecurrent.com/trials/relugolix-and-enzalutamide-in-combination-with-radiation-therapy-for-the-treatment-of-very-high-risk-prostate-cancer-opt-55505https://curecurrent.com/trials/mri-guided-focal-laser-ablation-of-prostate-cancer-55506https://curecurrent.com/trials/drug-durg-interaction-of-shr3680-with-digoxin-rosuvastatin-calcium-and-metformin-hydrochloride-55507https://curecurrent.com/trials/moderate-hypofractionated-boost-to-the-prostate-with-pelvic-rt-in-high-risk-prostate-cancer-55508https://curecurrent.com/trials/diagnosing-clinically-significant-prostate-cancer-in-african-american-and-white-men-with-elevated-psa-55509https://curecurrent.com/trials/prostate-oncologic-therapy-while-ensuring-neurovascular-conservation-poten-c-55510https://curecurrent.com/trials/safety-pharmacokinetic-and-proof-of-concept-study-of-arn-509-apalutamide-in-castration-resistant-prostate-cancer-crpc-55511https://curecurrent.com/trials/tumor-microenvironment-analysis-of-prostate-cancer-metastasis-55512https://curecurrent.com/trials/cabozantinib-and-atezolizumab-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-55513https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-pharmacodynamics-and-antitumor-activity-of-inv-9956-in-adult-patients-wi-55514https://curecurrent.com/trials/neoadjuvant-atezolizumab-based-combination-therapy-in-men-with-localized-prostate-cancer-prior-to-radical-prostatectomy-55515https://curecurrent.com/trials/trans-and-non-binary-prostate-specific-antigen-reference-interval-determination-study-55516https://curecurrent.com/trials/sacituzumab-govitecan-in-patients-with-metastatic-castration-resistant-prostate-cancer-progressing-on-second-generation-55517https://curecurrent.com/trials/a-multi-modal-physician-centered-intervention-to-improve-guideline-concordant-prostate-cancer-imaging-55518https://curecurrent.com/trials/an-ai-platform-integrating-imaging-data-and-models-supporting-precision-care-through-prostate-cancer-s-continuum-55519https://curecurrent.com/trials/highly-metastatic-life-prolonging-therapy-resistant-prostate-cancer-role-of-stereotactic-radiotherapy-for-bone-and-lymph-55520https://curecurrent.com/trials/long-term-safety-of-lutetium-177lu-vipivotide-tetraxetan-in-participants-with-prostate-cancer-55521https://curecurrent.com/trials/zanzalintinib-efficacy-post-pluvicto-in-chemotherapy-na-ve-metastatic-castration-resistant-prostate-cancer-55522https://curecurrent.com/trials/psma-guided-ablation-of-the-prostate-55523https://curecurrent.com/trials/enzalutamide-with-or-without-radium-ra-223-dichloride-in-patients-with-metastatic-castration-resistant-prostate-cancer-55524https://curecurrent.com/trials/creatine-supplementation-and-resistance-training-to-preserve-muscle-mass-and-attenuate-cancer-progression-55525https://curecurrent.com/trials/cuimc-focal-therapy-registry-55526https://curecurrent.com/trials/terps-trial-for-de-novo-oligometastic-prostate-cancer-55527https://curecurrent.com/trials/golf-recreational-exercise-for-enhanced-survivorship-in-prostate-cancer-survivors-55528https://curecurrent.com/trials/imaging-and-genomic-biomarkers-to-predict-response-in-prostate-cancer-55529https://curecurrent.com/trials/study-of-sx-682-plus-enzalutamide-in-men-with-arpi-resistant-metastatic-castration-resistant-prostate-cancer-55530https://curecurrent.com/trials/an-evidence-based-focal-cryotherapy-protocol-for-focal-ablation-of-intermediate-risk-prostate-cancer-55531https://curecurrent.com/trials/pivotal-study-of-the-nanoknife-system-for-the-ablation-of-prostate-tissue-55532https://curecurrent.com/trials/reflexion-pet-ct-imaging-performance-in-patients-with-prostate-cancer-55533https://curecurrent.com/trials/exploring-auger-enhanced-psma-targeted-radioligand-therapy-a-first-in-taiwan-clinical-study-of-161tb-psma-i-t-55534https://curecurrent.com/trials/agn-cogni-q-acute-dose-safety-and-pharmacokinetics-dose-response-in-prostate-cancer-patients-55535https://curecurrent.com/trials/a-clinical-study-of-qlc5508-and-or-qlh12016-in-combination-with-other-anti-tumor-therapies-in-subjects-with-advanced-pro-55536https://curecurrent.com/trials/is-adaptive-sbrt-for-prostate-vs-image-guided-radiotherapy-a-true-evolution-aspire-55537https://curecurrent.com/trials/psca-car-t-cells-in-treating-patients-with-psca-metastatic-castration-resistant-prostate-cancer-55538https://curecurrent.com/trials/early-diagnosis-of-prostate-cancer-for-black-men-55539https://curecurrent.com/trials/pragmatic-trial-of-metformin-for-glucose-intolerance-or-increased-bmi-in-prostate-cancer-patients-55540https://curecurrent.com/trials/study-of-nivolumab-in-combination-w-radium-223-in-men-w-metastatic-castration-resistant-prostate-cancer-55541https://curecurrent.com/trials/robot-assisted-radical-prostatectomy-with-or-without-vesicopexy-in-patients-with-prostate-cancer-55542https://curecurrent.com/trials/a-phase-i-trial-of-a-car032-in-participants-with-mcrpc-55543https://curecurrent.com/trials/safety-and-diagnostic-performance-of-upar-pet-imaging-in-localised-untreated-prostate-cancer-55544https://curecurrent.com/trials/expanding-genetic-access-for-prostate-cancer-survivors-55545https://curecurrent.com/trials/ptvg-hp-and-nivolumab-in-patients-with-non-metastatic-psa-recurrent-prostate-cancer-55546https://curecurrent.com/trials/177lu-psma-617-with-liver-directed-therapy-in-metastatic-castration-resistant-prostate-cancer-55547https://curecurrent.com/trials/cytalux-for-the-intraoperative-imaging-of-prostate-cancer-55548https://curecurrent.com/trials/abiraterone-prednisone-olaparib-or-abiraterone-prednisone-olaparib-in-patients-with-metastatic-castration-resistant-pros-55549https://curecurrent.com/trials/prostate-androgen-response-investigation-using-a-stratification-biomarker-predicting-prostate-cancer-downstaging-by-neoa-55550https://curecurrent.com/trials/magnethermopro-magnetic-resonance-thermography-of-human-prostate-55551https://curecurrent.com/trials/multimodal-imaging-and-digital-pathology-for-prostate-cancer-prediction-55552https://curecurrent.com/trials/androgen-responsive-posluma-guided-intra-prostatic-boost-55553https://curecurrent.com/trials/a-study-of-trc003-in-the-treatment-of-patients-with-progressive-psma-positive-mcrpc-55554https://curecurrent.com/trials/how-darolutamide-plus-hormone-therapy-works-for-men-with-advanced-prostate-cancer-in-everyday-medical-practice-in-german-55555https://curecurrent.com/trials/the-use-of-artificial-intelligence-generated-contours-in-radiation-planning-of-the-prostate-brachytherapy-55556https://curecurrent.com/trials/intra-operative-optical-imaging-with-mdx1201-a488-in-patients-with-prostate-cancer-55557https://curecurrent.com/trials/efficacy-of-intraoperative-arista-polysaccharide-application-on-the-postoperative-blood-loss-in-patients-undergoing-rarp-55558https://curecurrent.com/trials/a-clinical-trial-evaluating-the-safety-of-td001-in-patients-with-psma-expressing-metastatic-prostate-cancer-55559https://curecurrent.com/trials/prism-patient-experiences-with-pet-imaging-in-prostate-cancer-55560https://curecurrent.com/trials/predicting-location-and-extent-of-prostate-cancer-using-micro-ultrasound-imaging-55561https://curecurrent.com/trials/psma-pet-mri-guided-prostate-biopsy-for-pi-rads-3-and-prior-negative-biopsy-55562https://curecurrent.com/trials/sipuleucel-t-based-autologous-cellular-immunotherapy-for-advanced-prostate-cancer-55563https://curecurrent.com/trials/management-of-oligoprogressive-castration-resistant-prostate-cancer-pcs-x-55564https://curecurrent.com/trials/effects-of-rectal-indomethacin-suppository-on-postoperative-crbd-in-patients-undergoing-lrp-55565https://curecurrent.com/trials/predictors-of-nodal-and-distant-metastatic-disease-detected-by-psma-pet-in-treatment-na-ve-high-risk-prostate-cancer-a-c-55566https://curecurrent.com/trials/amniox-cord-study-radical-prostatectomy-with-and-without-cryopreserved-umbilical-cord-allograft-55567https://curecurrent.com/trials/cascara-castration-sensitive-carboplatin-cabazitaxel-and-abiraterone-55568https://curecurrent.com/trials/177-lutetium-psma-before-stereotactic-body-radiotherapy-for-the-treatment-of-oligorecurrent-prostate-cancer-the-lunar-st-55569https://curecurrent.com/trials/hypofractionated-radiation-therapy-for-treating-prostate-cancer-high-risk-features-following-radical-prostatectomy-55570https://curecurrent.com/trials/study-with-225ac-ac-fl-020-in-mcrpc-participants-55571https://curecurrent.com/trials/multicenter-randomized-trial-of-68ga-psma-11-pet-ct-based-srt-after-radical-prostatectomy-55572https://curecurrent.com/trials/high-dose-lymph-node-intensity-modulated-radiation-therapy-and-hypofractionated-prostate-sib-55573https://curecurrent.com/trials/formulating-expert-consensus-guidelines-in-cancer-care-using-the-delphi-method-55574https://curecurrent.com/trials/active-surveillance-for-cancer-of-the-prostate-ascap-55575https://curecurrent.com/trials/stereotactic-body-radiotherapy-and-177lutetium-psma-in-locally-advanced-prostate-cancer-55576https://curecurrent.com/trials/the-effect-of-pelvic-floor-muscle-exercises-after-radical-prostatectomy-55577https://curecurrent.com/trials/salvage-mr-guided-high-dose-rate-brachytherapy-for-prostate-bed-recurrence-after-radiotherapy-in-the-psma-pet-scan-era-55578https://curecurrent.com/trials/frailty-in-older-adults-with-prostate-cancer-a-prospective-cohort-study-55579https://curecurrent.com/trials/hemi-gland-cryoablation-for-prostate-cancer-at-ucla-55580https://curecurrent.com/trials/a-study-of-lorigerlimab-with-docetaxel-or-docetaxel-alone-in-participants-with-metastatic-castration-resistant-prostate-55581https://curecurrent.com/trials/high-risk-prostate-cancer-radiation-versus-surgery-55582https://curecurrent.com/trials/multimodal-machine-learning-characterization-of-solid-tumors-55583https://curecurrent.com/trials/trial-comparing-irradiation-plus-long-term-adjuvant-androgen-deprivation-with-gnrh-antagonist-versus-gnrh-agonist-plus-f-55584https://curecurrent.com/trials/onc-392-plus-lutetium-lu-177-vipivotide-tetraxetan-in-patients-with-mcrpc-55585https://curecurrent.com/trials/neoadjuvant-androgen-deprivation-therapy-combined-with-enzalutamide-and-abiraterone-using-multiparametric-mri-and-18fdcf-55586https://curecurrent.com/trials/focal-radiation-therapy-hdr-brachytherapy-for-the-treatment-of-prostate-cancer-55587https://curecurrent.com/trials/international-registry-for-men-with-advanced-prostate-cancer-ironman-55588https://curecurrent.com/trials/ultra-hypofractionated-carbon-ion-therapy-for-prostate-cancer-55589https://curecurrent.com/trials/genetic-analysis-of-prostate-cancer-to-identify-predictive-markers-of-disease-relapse-or-metastatic-evolution-55590https://curecurrent.com/trials/a-study-of-ds9051b-in-participants-with-advanced-or-metastatic-adrenocortical-carcinoma-and-metastatic-castration-resist-55591https://curecurrent.com/trials/mediterranean-diet-intervention-among-men-at-lbj-hospital-with-prostate-cancer-55592https://curecurrent.com/trials/a-clinical-study-evaluating-the-safety-and-efficacy-of-local-injection-of-act-001-chimeric-antigen-receptor-t-cells-in-t-55593https://curecurrent.com/trials/robotic-opioid-free-prostatectomy-enhanced-strategy-ropes-55594https://curecurrent.com/trials/conventional-or-hypofractionated-radiation-therapy-in-treating-patients-with-prostate-cancer-55595https://curecurrent.com/trials/ds3201-and-ipilimumab-for-the-treatment-of-metastatic-prostate-urothelial-and-renal-cell-cancers-55596https://curecurrent.com/trials/comparative-analysis-of-immunological-responses-to-vitamin-d-replacement-therapy-in-black-and-west-african-men-diagnosed-55597https://curecurrent.com/trials/aborption-and-metabolism-of-lyophilized-black-raspberry-food-products-in-men-with-prostate-cancer-undergoing-surgery-55598https://curecurrent.com/trials/daily-adaptive-post-prostatectomy-with-stereotactic-ablative-radiotherapy-in-patients-with-prostate-cancer-55599https://curecurrent.com/trials/tivozanib-enzalutamide-in-adv-prostate-cancer-55600https://curecurrent.com/trials/stereotactic-prostate-adaptive-radiotherapy-utilising-kilovoltage-intrafraction-monitoring-55601https://curecurrent.com/trials/everist-impact-of-image-detected-accessory-pudendal-artery-on-erection-recovery-after-nerve-sparing-prostatectomy-55602https://curecurrent.com/trials/dyadic-co-learning-intervention-for-patients-with-prostate-cancer-and-their-spouses-55603https://curecurrent.com/trials/microwave-intervention-under-local-anesthesia-55604https://curecurrent.com/trials/dose-escalation-study-using-ultra-hypofractionated-image-guided-intensity-modulated-radiotherapy-in-prostate-cancer-55605https://curecurrent.com/trials/high-resolution-intra-operative-psma-pet-ct-in-prostate-cancer-55606https://curecurrent.com/trials/hyperpolarized-pyruvate-13c-mr-imaging-in-monitoring-patients-with-prostate-cancer-on-active-surveillance-55607https://curecurrent.com/trials/pilot-study-of-an-implantable-microdevice-for-evaluating-drug-responses-in-situ-in-prostate-cancer-55608https://curecurrent.com/trials/a-study-of-mevrometostat-with-enzalutamide-in-people-with-prostate-cancer-who-have-previously-received-androgen-receptor-55609https://curecurrent.com/trials/a-study-to-evaluate-the-performance-of-confocal-microscopy-to-detect-positive-margins-during-radical-prostatectomy-55610https://curecurrent.com/trials/artificial-intelligence-prostate-cancer-55611https://curecurrent.com/trials/molecular-profiling-of-mri-psma-pet-discordance-in-prostate-cancer-55612https://curecurrent.com/trials/hormone-therapy-and-intensity-modulated-radiation-therapy-in-treating-patients-with-metastatic-prostate-cancer-55613https://curecurrent.com/trials/nivolumab-in-biochemically-recurrent-dmmr-prostate-cancer-55614https://curecurrent.com/trials/carboplatin-enhanced-therapy-in-brca-mutated-or-neuroendocrine-differentiated-aggressive-metastatic-castration-sensitive-55615https://curecurrent.com/trials/phase-2-study-of-neoadjuvant-pembrolizumab-before-radical-prostatectomy-in-high-risk-prostate-cancer-patients-55616https://curecurrent.com/trials/a-study-comparing-infectious-complications-after-transperineal-prostate-biopsy-with-or-without-antibiotic-prophylaxis-55617https://curecurrent.com/trials/a-trial-of-bxcl701-and-pembrolizumab-in-patients-with-mcrpc-either-small-cell-neuroendocrine-prostate-cancer-or-adenocar-55618https://curecurrent.com/trials/prostate-cancer-screening-for-people-at-genetic-risk-for-aggressive-disease-patrol-study-55619https://curecurrent.com/trials/study-to-evaluate-exicorilant-cort125281-in-combination-with-enzalutamide-in-patients-with-metastatic-castration-resista-55620https://curecurrent.com/trials/a-study-of-valemetostat-ds-3201b-in-combination-with-darolutamide-in-metastatic-castration-resistant-prostate-cancer-mcr-55621https://curecurrent.com/trials/shared-decision-making-in-low-risk-prostate-cancer-55622https://curecurrent.com/trials/phase-2a-study-of-high-dose-testosterone-followed-by-radioligand-therapy-in-mcrpc-55623https://curecurrent.com/trials/phase-3-study-of-xaluritamig-vs-cabazitaxel-or-second-androgen-receptor-directed-therapy-in-participants-with-progressiv-55624https://curecurrent.com/trials/observational-study-on-lutetium-177lu-vipivotide-tetraxetan-to-treat-metastatic-castration-resistant-prostate-cancer-55625https://curecurrent.com/trials/study-of-bortezomib-and-docetaxel-for-patients-with-hormone-refractory-prostate-cancer-55626https://curecurrent.com/trials/a-tailored-polygenic-risk-score-for-predicting-progression-in-prostate-cancer-under-active-surveillance-55627https://curecurrent.com/trials/extending-prostate-genetic-awareness-navigation-and-delivery-the-expand-network-55628https://curecurrent.com/trials/dmd-002-pilot-study-in-patients-with-cavernous-nerve-injury-following-radical-prostatectomy-55629https://curecurrent.com/trials/68ga-psma-11-pet-for-the-diagnosis-of-metastatic-castration-resistant-prostate-cancer-55630https://curecurrent.com/trials/pilot-study-of-dose-escalation-in-prostate-radiotherapy-using-the-mr-linac-destination-mrl-55631https://curecurrent.com/trials/development-of-a-novel-signature-integrating-clinical-imaging-and-epigenetic-information-to-tailor-pelvic-nodal-treatmen-55632https://curecurrent.com/trials/flotufolastat-f-18-pet-in-men-with-very-low-psa-recurrence-55633https://curecurrent.com/trials/multi-omics-analysis-of-prostate-derived-extracellular-vesicles-an-observational-retrospective-study-for-prostate-cancer-55634https://curecurrent.com/trials/64cu-sar-bispsma-positron-emission-tomography-a-phase-3-study-of-participants-with-biochemical-recurrence-of-prostate-ca-55635https://curecurrent.com/trials/68ga-rm2-compared-to-68ga-psma-617-pet-ct-for-prostate-cancer-imaging-according-to-various-metastatic-risks-55636https://curecurrent.com/trials/prostic-registry-of-men-treated-with-psma-theranostics-55637https://curecurrent.com/trials/targeted-radiotherapy-in-androgen-suppressed-prostate-cancer-patients-55638https://curecurrent.com/trials/impact-of-body-composition-on-dosimetry-of-177lu-psma-radioligand-therapy-55639https://curecurrent.com/trials/anti-tumour-activity-of-177lu-rhpsma-10-1-injection-55640https://curecurrent.com/trials/a-study-to-test-radium-223-with-docetaxel-in-patients-with-prostate-cancer-55641https://curecurrent.com/trials/niraparib-before-surgery-in-treating-patients-with-high-risk-localized-prostate-cancer-and-dna-damage-response-defects-55642https://curecurrent.com/trials/testosterone-replacement-therapy-for-the-treatment-of-low-testosterone-in-hypogonadal-men-with-localized-prostate-cancer-55643https://curecurrent.com/trials/multicenter-trial-of-esk981-in-patients-with-select-solid-tumors-55644https://curecurrent.com/trials/pembrolizumab-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-previously-treated-with-enzaluta-55645https://curecurrent.com/trials/percutaneous-thermo-ablation-for-the-treatment-of-prostate-cancer-oligometastatasis-ta-p-olim-55646https://curecurrent.com/trials/plasma-analysis-for-response-assessment-and-to-direct-the-management-of-metastatic-prostate-cancer-55647https://curecurrent.com/trials/ys247-neoantigen-pulsed-dc-vaccine-for-metastatic-prostate-cancer-55648https://curecurrent.com/trials/coast-therapy-in-advanced-solid-tumors-and-prostate-cancer-55649https://curecurrent.com/trials/selecting-hypoxic-tumours-for-treatment-modification-55650https://curecurrent.com/trials/curcumin-and-piperine-in-patients-on-surveillance-for-monoclonal-gammopathy-smoldering-myeloma-or-prostate-cancer-55651https://curecurrent.com/trials/olaparib-in-men-with-high-risk-biochemically-recurrent-prostate-cancer-following-radical-prostatectomy-with-integrated-b-55652https://curecurrent.com/trials/hypofractionated-image-guided-radiotherapy-igrt-with-organ-motion-mitigation-and-urethral-sparing-for-prostate-cancer-55653https://curecurrent.com/trials/salvage-stereotactic-body-radiotherapy-of-the-prostate-bed-for-biochemical-recurrence-after-radical-prostatectomy-55654https://curecurrent.com/trials/a-phase-i-study-of-225ac-azd2284-in-patients-with-metastatic-castration-resistant-prostate-cancer-55655https://curecurrent.com/trials/bilateral-versus-unilateral-lymph-node-dissection-in-high-risk-prostate-cancer-balance-55656https://curecurrent.com/trials/quality-and-safety-of-real-time-brachytherapy-treatments-clinical-implementation-of-a-multipoint-scintillation-detector-55657https://curecurrent.com/trials/phase-ia-ib-talazoparib-tazemetostat-for-mcrpc-55658https://curecurrent.com/trials/a-phase-iii-clinical-study-of-rezvilutamide-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-55659https://curecurrent.com/trials/ct-guided-stereotactic-body-radiation-therapy-and-mri-guided-stereotactic-body-radiation-therapy-for-prostate-cancer-mir-55660https://curecurrent.com/trials/pembrolizumab-and-lenvatinib-in-advanced-metastatic-neuroendocrine-prostate-cancer-55661https://curecurrent.com/trials/hypofractionated-accelerated-pelvic-nodal-radiotherapy-gcc-2048-55662https://curecurrent.com/trials/pain-comparison-transrectal-vs-transperineal-prostate-biopsy-55663https://curecurrent.com/trials/study-of-abiraterone-acetate-or-enzalutamide-atezolizumab-gnrh-analog-and-radiation-therapy-in-men-with-newly-diagnosed-55664https://curecurrent.com/trials/study-of-177lu-psma-617-in-metastatic-castrate-resistant-prostate-cancer-in-japan-55665https://curecurrent.com/trials/177lu-psma-617-in-metastatic-castration-resistant-prostate-cancer-mcrpc-with-bone-marrow-involvement-and-cytopenia-55666https://curecurrent.com/trials/zen003694-and-enzalutamide-versus-enzalutamide-monotherapy-in-metastatic-castration-resistant-prostate-cancer-55667https://curecurrent.com/trials/internet-based-lifestyle-intervention-to-eradicate-obese-frailty-in-prostate-cancer-survivors-ilive-55668https://curecurrent.com/trials/androgen-deprivation-therapy-and-radiation-therapy-in-treating-patients-with-prostate-cancer-55669https://curecurrent.com/trials/surgery-with-or-without-darolutamide-in-high-risk-and-or-locally-advanced-prostate-cancer-55670https://curecurrent.com/trials/actinium-in-castrate-resistant-prostate-cancer-after-lutetium-55671https://curecurrent.com/trials/continuation-protocol-for-zen003694-in-patients-experiencing-clinical-benefit-while-enrolled-in-a-zen003694-protocol-55672https://curecurrent.com/trials/single-dose-image-guided-radiotherapy-with-urethral-sparing-and-dil-boost-for-intermediate-risk-prostate-cancer-prosint-55673https://curecurrent.com/trials/nivolumab-in-patients-with-high-risk-biochemically-recurrent-prostate-cancer-55674https://curecurrent.com/trials/mri-guided-cryoablation-for-focal-native-prostate-cancer-55675https://curecurrent.com/trials/low-to-moderate-load-power-training-for-men-with-metastatic-prostate-cancer-55676https://curecurrent.com/trials/nutrition-and-exercise-interventions-for-androgen-deprivation-therapy-induced-obese-frailty-in-elderly-and-non-elderly-s-55677https://curecurrent.com/trials/predicting-cognitive-decline-from-androgen-deprivation-therapy-55678https://curecurrent.com/trials/get-fit-together-testing-a-socially-enhanced-exercise-program-in-older-men-with-prostate-cancer-55679https://curecurrent.com/trials/64cu-sar-bispsma-and-67cu-sar-bispsma-for-identification-and-treatment-of-psma-expressing-metastatic-castrate-resistant-55680https://curecurrent.com/trials/darolutamide-augments-standard-therapy-for-localised-very-high-risk-cancer-of-the-prostate-55681https://curecurrent.com/trials/comprehensive-evaluation-of-mri-ai-in-prostate-cancer-diagnosis-55682https://curecurrent.com/trials/utilization-of-flotufolastat-18f-pet-for-post-focal-therapy-prostate-cancer-evaluation-55683https://curecurrent.com/trials/comparing-psma-pet-ct-and-mri-rsi-for-finding-and-outlining-tumors-inside-the-prostate-in-men-with-newly-diagnosed-prost-55684https://curecurrent.com/trials/a-pilot-study-evaluating-the-effect-of-2d-antiscatter-grids-on-cbct-image-quality-55685https://curecurrent.com/trials/trial-of-acetylsalicylic-acid-and-atorvastatin-in-patients-with-castrate-resistant-prostate-cancer-55686https://curecurrent.com/trials/enhancing-readability-of-lay-abstracts-and-summaries-for-medical-knowledge-using-generative-artificial-intelligence-brid-55687https://curecurrent.com/trials/high-risk-metachronous-oligometastatic-prostate-cancer-trial-55688https://curecurrent.com/trials/enzalutamide-in-androgen-deprivation-therapy-with-radiation-therapy-for-high-risk-clinically-localised-prostate-cancer-55689https://curecurrent.com/trials/the-impact-of-androgen-ablation-therapy-on-cognitive-functioning-and-functional-status-in-men-with-prostate-cancer-age-6-55690https://curecurrent.com/trials/5500-20-vs-sabr-or-brachytherapy-for-primary-oligometastatic-prostate-cancer-treatment-prompt-55691https://curecurrent.com/trials/enzalutamide-and-niclosamide-in-treating-patients-with-recurrent-or-metastatic-castration-resistant-prostate-cancer-55692https://curecurrent.com/trials/mri-mapped-dose-escalated-salvage-radiotherapy-post-prostatectomy-the-maps-trial-55693https://curecurrent.com/trials/ultra-hypofractionated-radiation-in-prostate-cancer-55694https://curecurrent.com/trials/immunotherapy-before-and-after-surgery-55695https://curecurrent.com/trials/avelumab-utomilumab-anti-ox40-antibody-pf-04518600-and-radiation-therapy-in-treating-patients-with-advanced-malignancies-55696https://curecurrent.com/trials/a-trial-to-find-out-if-regn4336-is-safe-and-how-well-it-works-alone-and-in-combination-with-regn5678-for-adult-participa-55697https://curecurrent.com/trials/ruxolitinib-and-enzalutamide-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-55698https://curecurrent.com/trials/xmab-20717-vudalimab-alone-or-in-combination-with-chemotherapy-or-targeted-therapy-in-patients-with-metastatic-castratio-55699https://curecurrent.com/trials/immunotherapy-with-n-803-etbx-071-and-m-cenk-in-combination-with-radiation-for-participants-with-high-risk-prostate-canc-55700https://curecurrent.com/trials/magnetic-resonance-mr-imaging-with-hyperpolarized-bicarbonate-13c-to-measure-tissue-ph-in-prostate-cancer-55701https://curecurrent.com/trials/evaluation-of-prostate-specific-membrane-antigen-positron-emission-tomography-computed-tomography-in-active-surveillance-55702https://curecurrent.com/trials/remotely-monitored-exercise-interventions-in-patients-with-mcspc-undergoing-adt-prostate-006-55703https://curecurrent.com/trials/water-iv-prostate-cancer-55704https://curecurrent.com/trials/feasibility-of-omnecoil-system-for-integrated-endorectal-mri-and-transrectal-mri-targeted-biopsy-of-the-prostate-55705https://curecurrent.com/trials/chlordecone-exposure-and-prostate-cancer-in-the-french-region-of-martiniique-55706https://curecurrent.com/trials/clinical-study-to-assess-the-safety-and-efficacy-of-the-spectracure-p18-system-55707https://curecurrent.com/trials/a-multi-center-trial-of-androgen-suppression-with-abiraterone-acetate-leuprolide-parp-inhibition-and-stereotactic-body-r-55708https://curecurrent.com/trials/transurethral-periprostatectomy-treatment-of-cancerous-prostate-tissue-55709https://curecurrent.com/trials/promet-br-molecular-profiling-of-metastatic-prostate-cancer-a-brazilian-cohort-55710https://curecurrent.com/trials/photodynamic-therapy-of-primary-localized-prostate-cancer-with-the-spectracure-p18-system-55711https://curecurrent.com/trials/prospective-clinical-trial-of-177lu-p17-088-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer-55712https://curecurrent.com/trials/prostate-interstitial-brachytherapy-with-i125-implant-with-target-dose-supplementation-in-the-tumor-volume-guided-by-tri-55713https://curecurrent.com/trials/cabozantinib-in-patients-with-metastatic-castrate-resistant-prostate-cancer-mcrpc-55714https://curecurrent.com/trials/pilot-study-of-mr-imaging-with-pyruvate-13c-to-detect-high-grade-prostate-cancer-55715https://curecurrent.com/trials/improving-patient-understanding-of-their-prostate-cancer-diagnosis-using-ai-55716https://curecurrent.com/trials/understanding-the-benefits-of-dietary-fibre-supplementation-in-patients-with-prostate-cancer-55717https://curecurrent.com/trials/study-of-225ac-psma-617-in-men-with-psma-positive-prostate-cancer-55718https://curecurrent.com/trials/phase-iii-adaptive-adaptive-stereostactic-body-radiotherapy-sbrt-with-dose-escalation-for-high-risk-prostate-cancer-55719https://curecurrent.com/trials/shr-1701-in-combination-with-stereotactic-body-radiotherapy-in-mcrpc-55720https://curecurrent.com/trials/theranostic-applications-of-radionuclides-in-prostate-cancer-55721https://curecurrent.com/trials/prospective-clinical-trial-of-225ac-lnc1011-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer-55722https://curecurrent.com/trials/mri-guided-locoregional-sbrt-prostate-program-55723https://curecurrent.com/trials/an-international-multicenter-clinical-study-on-application-of-uromed-ai-doctor-based-on-large-language-models-55724https://curecurrent.com/trials/hypofractionated-radiosurgery-for-localised-prostate-cancer-hypostat-iii-55725https://curecurrent.com/trials/docetaxel-and-prostvac-for-metastatic-castration-sensitive-prostate-cancer-55726https://curecurrent.com/trials/impact-of-exercise-on-mitochondria-in-cancer-patients-55727https://curecurrent.com/trials/imaging-of-solid-tumors-using-dll3-spect-55728https://curecurrent.com/trials/a-study-of-stereotactic-body-radiation-therapy-and-radium-ra-223-dichloride-in-prostate-cancer-that-has-spread-to-the-bo-55729https://curecurrent.com/trials/plasma-exosomal-rna-signature-for-prostate-cancer-bone-metastasis-55730https://curecurrent.com/trials/adt-darolutamide-in-de-novo-metastatic-prostate-cancer-patients-with-vulnerable-functional-ability-peace6-vulnerable-55731https://curecurrent.com/trials/ai-based-measurements-of-tumour-burden-in-psma-pet-ct-55732https://curecurrent.com/trials/ferumoxtran-10-enhanced-mri-in-prostate-cancer-patients-55733https://curecurrent.com/trials/quality-of-life-functional-and-cognitive-outcomes-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-55734https://curecurrent.com/trials/trial-of-arv-110-and-abiraterone-in-participants-with-metastatic-prostate-cancer-55735https://curecurrent.com/trials/a-comparative-dose-finding-study-of-rs-113-in-patients-with-metastatic-castration-resistant-prostate-cancer-55736https://curecurrent.com/trials/serial-psma-pet-for-therapy-monitoring-in-clinically-significant-prostate-cancer-55737https://curecurrent.com/trials/the-enhancement-of-diagnostic-and-grading-efficacy-of-prostate-cancer-by-new-mri-sequences-a-prospective-observational-s-55738https://curecurrent.com/trials/a-study-of-opevesostat-mk-568-4-in-japanese-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc-mk-5-55739https://curecurrent.com/trials/predictive-factors-for-10-year-biochemical-recurrence-and-urinary-continence-following-robot-assisted-radical-prostatect-55740https://curecurrent.com/trials/18f-rhpsma-pet-ct-imaging-performance-in-patients-with-prostate-cancer-55741https://curecurrent.com/trials/ebrt-and-hdr-brachytherapy-for-unfavorable-intermediate-high-and-very-high-risk-prostate-cancer-55742https://curecurrent.com/trials/multi-arm-multi-modality-therapy-for-very-high-risk-localized-and-low-volume-metastatic-prostatic-adenocarcinoma-55743https://curecurrent.com/trials/study-evaluating-zenocutuzumab-in-patients-with-or-without-molecularly-defined-cancers-55744https://curecurrent.com/trials/intestinal-akkermansia-muciniphila-in-prostate-cancer-55745https://curecurrent.com/trials/working-out-m0-bipolar-androgen-therapy-55746https://curecurrent.com/trials/focal-laser-ablation-of-prostate-cancer-55747https://curecurrent.com/trials/bipolar-androgen-therapy-carboplatin-in-mcrpc-55748https://curecurrent.com/trials/single-fraction-early-prostate-irradiation-sifepi-55749https://curecurrent.com/trials/metabolic-impact-and-compliance-of-controlled-varying-mediterranean-diets-in-pre-surgical-prostate-cancer-populations-pr-55750https://curecurrent.com/trials/randomized-trial-of-five-or-two-mri-guided-adaptive-radiotherapy-treatments-for-prostate-cancer-55751https://curecurrent.com/trials/lab-research-using-mini-tumors-to-study-prostate-cancer-treatments-55752https://curecurrent.com/trials/determination-of-baseline-levels-for-prostate-cancer-derived-extracellular-vesicles-following-local-treatment-of-prostat-55753https://curecurrent.com/trials/multicentric-comparative-prospective-study-of-the-benefits-and-risks-of-biopsy-prostate-using-transrectal-or-transperine-55754https://curecurrent.com/trials/laparoscopic-tap-block-during-robotic-assisted-laparoscopic-radical-prostatectomy-for-improvement-in-postoperative-pain-55755https://curecurrent.com/trials/ceralasertib-azd6738-alone-and-in-combination-with-olaparib-or-durvalumab-in-patients-with-solid-tumors-55756https://curecurrent.com/trials/psma-intensity-can-be-altered-by-androgen-and-phospho-src-obstruction-55757https://curecurrent.com/trials/phase-ii-high-dose-brachytherapy-and-low-dose-rate-brachytherapy-as-monotherapy-in-localized-prostate-cancer-55758https://curecurrent.com/trials/enzalutamide-with-ribociclib-in-treating-patients-with-metastatic-castrate-resistant-chemotherapy-naive-prostate-cancer-55759https://curecurrent.com/trials/clinical-trial-of-approaches-to-prostate-cancer-surgery-55760https://curecurrent.com/trials/intermittent-fasting-in-prostate-cancer-patients-receiving-androgen-deprivation-therapy-55761https://curecurrent.com/trials/phase-i-ii-trial-of-pembrolizumab-and-androgen-receptor-inhibitor-with-or-without-225ac-j591-for-progressive-metastatic-55762https://curecurrent.com/trials/a-clinical-study-of-shr-4394-in-combination-with-anti-tumor-therapy-in-prostate-cancer-55763https://curecurrent.com/trials/clinical-study-to-assess-the-efficacy-and-safety-of-olaparib-in-chinese-patients-with-metastatic-castration-resistant-pr-55764https://curecurrent.com/trials/robotic-telesurgery-in-urology-55765https://curecurrent.com/trials/a-study-of-apalutamide-adjuvant-treatment-and-androgen-deprivation-therapy-adt-in-participants-who-have-undergone-radica-55766https://curecurrent.com/trials/comparison-of-radical-prostatectomy-performed-by-robot-assisted-laparoscopy-or-conventional-laparoscopy-or-by-laparotomy-55767https://curecurrent.com/trials/phase-i-trial-of-apalutamide-plus-abiraterone-acetate-docetaxel-and-prednisone-in-patients-with-mcrpc-55768https://curecurrent.com/trials/177-lu-psma-617-in-combination-with-sipuleucel-t-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-55769https://curecurrent.com/trials/a-study-of-jnj-75229414-for-metastatic-castration-resistant-prostate-cancer-participants-55770https://curecurrent.com/trials/outcomes-of-focal-ablation-for-prostate-cancer-55771https://curecurrent.com/trials/study-of-the-epidemiological-clinical-diagnostic-and-therapeutic-characteristics-of-prostate-cancers-in-algeria-55772https://curecurrent.com/trials/a-prospective-phase-ii-dose-escalation-study-using-imrt-for-high-risk-n0-m0-prostate-cancer-icorg-08-17-55773https://curecurrent.com/trials/improvements-in-dynamic-contrast-enhanced-mr-angiography-and-perfusion-and-non-contrast-mri-55774https://curecurrent.com/trials/evaluation-of-an-online-prostate-cancer-screening-decision-aid-55775https://curecurrent.com/trials/3d1015-injection-for-patients-with-mcrpc-55776https://curecurrent.com/trials/hifu-for-focal-ablation-of-prostate-tissue-an-observational-study-55777https://curecurrent.com/trials/a-study-of-2141-v11-in-combination-with-standard-treatments-in-people-with-prostate-cancer-55778https://curecurrent.com/trials/tumor-genomic-pre-test-counseling-tool-for-black-or-african-american-men-with-prostate-cancer-55779https://curecurrent.com/trials/platinum-and-taxane-chemo-in-met-castration-resistant-prostate-cancer-patients-with-alterations-in-dna-damage-response-g-55780https://curecurrent.com/trials/ga-68-psma-pet-ct-vs-mpmri-in-cognitive-prostate-biopsy-55781https://curecurrent.com/trials/green-tea-and-quercetin-in-combination-with-docetaxel-chemotherapy-in-castration-resistant-prostate-cancer-patients-55782https://curecurrent.com/trials/lifestyle-intervention-for-the-reduction-of-prostate-cancer-disparities-among-african-americans-55783https://curecurrent.com/trials/low-flow-versus-minimal-flow-sevoflurane-anesthesia-during-robot-assisted-laparoscopic-radical-prostatectomy-55784https://curecurrent.com/trials/study-of-trdc002-in-the-diagnosis-of-patients-with-psma-positive-prostate-cancer-55785https://curecurrent.com/trials/cryoablation-combined-with-stereotactic-body-radiation-therapy-for-the-treatment-of-painful-bone-metastases-the-crome-tr-55786https://curecurrent.com/trials/delayed-psma-pet-ct-imaging-for-diagnosing-clinically-significant-prostate-cancer-in-biopsy-na-ve-men-with-suspected-pro-55787https://curecurrent.com/trials/peer-navigation-for-the-support-of-metastatic-prostate-cancer-patients-undergoing-genetic-evaluation-55788https://curecurrent.com/trials/androgen-suppression-combined-with-nodal-irradiation-and-dose-escalated-prostate-treatment-55789https://curecurrent.com/trials/the-balance-study-black-and-mixed-men-s-lived-experience-with-prostate-cancer-diversity-in-prostate-cancer-proms-study-55790https://curecurrent.com/trials/a-phase-2-3-psma-t4-prostate-cancer-55791https://curecurrent.com/trials/psma-pet-response-guided-sabr-in-high-risk-pca-55792https://curecurrent.com/trials/golimumab-and-apalutamide-for-the-treatment-of-castration-resistant-prostate-cancer-tramp-study-55793https://curecurrent.com/trials/phase-ii-study-of-feasibility-of-focal-therapy-for-prostate-cancer-of-good-prognosis-with-permanent-i125-localized-impla-55794https://curecurrent.com/trials/diagnostic-performance-of-18f-psma-1007-pet-ct-imaging-in-patients-with-newly-diagnosed-prostate-cancer-55795https://curecurrent.com/trials/efficacy-and-safety-evaluation-of-tarlatamab-in-advanced-extrapulmonary-neuroendocrine-carcinoma-patients-55796https://curecurrent.com/trials/posluma-18f-rhpsma-7-3-pet-ct-for-pirads-2-3-lesions-55797https://curecurrent.com/trials/aasur-in-high-risk-prostate-cancer-55798https://curecurrent.com/trials/investigating-the-diagnostic-performance-of-high-resolution-specimen-pet-ct-in-determining-margin-status-in-cancer-resec-55799https://curecurrent.com/trials/neo-adjuvant-abiraterone-prostate-study-55800https://curecurrent.com/trials/gedatolisib-in-combination-with-darolutamide-in-metastatic-castration-resistant-prostate-cancer-55801https://curecurrent.com/trials/castrate-resistant-prostate-cancer-enhertu-therapy-55802https://curecurrent.com/trials/fatty-acid-synthase-inhibition-in-castration-refractory-prostate-cancer-55803https://curecurrent.com/trials/multimodal-telerehabilitation-of-rural-patients-with-advanced-prostate-cancer-55804https://curecurrent.com/trials/denosumab-in-combination-with-enzalutamide-in-progressive-metastatic-castrate-resistant-prostate-cancer-and-bone-metasta-55805https://curecurrent.com/trials/posterior-extra-fascial-rarp-in-intermediate-or-high-risk-prostate-cancer-55806https://curecurrent.com/trials/feasibility-trial-of-image-guided-external-beam-radiotherapy-with-or-without-high-dose-rate-brachytherapy-boost-in-men-w-55807https://curecurrent.com/trials/phase-ii-study-of-pencil-beam-scanning-proton-stereotactic-body-radiation-therapy-for-prostate-cancer-55808https://curecurrent.com/trials/radium-223-in-combination-with-enzalutamide-55809https://curecurrent.com/trials/a-study-of-mhb048c-in-patients-with-advanced-solid-tumors-55810https://curecurrent.com/trials/radium-ra-223-dichloride-hormone-therapy-and-stereotactic-body-radiation-therapy-in-treating-patients-with-metastatic-pr-55811https://curecurrent.com/trials/cost-utility-of-focal-hifu-vs-prostatectomy-55812https://curecurrent.com/trials/the-effect-of-mobile-based-perioperative-education-on-urinary-incontinence-and-erectile-function-after-radical-prostatec-55813https://curecurrent.com/trials/lucarbo-a-study-of-177lu-psma-617-plus-carboplatin-in-metastatic-castrate-resistant-prostate-cancer-55814https://curecurrent.com/trials/prism-nlm-prostatectomy-intraoperative-surgical-margin-assessment-with-non-linear-microscopy-55815https://curecurrent.com/trials/cleveland-african-american-prostate-cancer-project-55816https://curecurrent.com/trials/niraparib-abiraterone-acetate-and-prednisone-for-mhspc-with-deleterious-homologous-recombination-repair-alterations-55817https://curecurrent.com/trials/safety-and-efficacy-of-docetaxel-darolutamide-and-homoharringtonine-combined-with-androgen-deprivation-therapy-in-neoadj-55818https://curecurrent.com/trials/fpi-2265-225ac-psma-i-t-for-patients-with-psma-positive-metastatic-castration-resistant-prostate-cancer-mcrpc-55819https://curecurrent.com/trials/moderately-hypofractionated-radiotherapy-for-prostate-cancer-55820https://curecurrent.com/trials/177lu-radiolabeled-monoclonal-antibody-huj591-177lu-j591-and-ketoconazole-in-patients-with-prostate-cancer-55821https://curecurrent.com/trials/helping-men-adhere-to-sexual-rehabilitation-following-prostate-cancer-surgery-55822https://curecurrent.com/trials/prognostic-value-of-early-postoperative-prostate-specific-antigen-for-oncological-outcomes-after-radical-prostatectomy-55823https://curecurrent.com/trials/veterans-affairs-seamless-phase-ii-iii-randomized-trial-of-standard-systemic-therapy-with-or-without-pet-directed-local-55824https://curecurrent.com/trials/open-radical-prostatectomy-versus-curative-radiotherapy-for-treatment-of-organ-confined-prostate-cancer-retrospective-co-55825https://curecurrent.com/trials/study-of-alpha-radioligand-therapy-ab001-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-55826https://curecurrent.com/trials/tsl2109-capsules-in-advanced-solid-tumor-patients-safety-tolerability-pk-and-preliminary-efficacy-55827https://curecurrent.com/trials/a-prospective-single-arm-pilot-study-of-the-alpfa-bph-pfa-system-in-men-with-low-intermediate-and-high-risk-prostate-can-55828https://curecurrent.com/trials/adaptive-radiotherapy-for-safe-hypofractionation-55829https://curecurrent.com/trials/microendoscopic-ei-sensing-for-real-time-intraoperative-surgical-margin-assessment-55830https://curecurrent.com/trials/efficacy-assessment-of-a-novel-3d-cartography-based-targeted-focal-microwave-therapy-in-men-with-localized-intermediate-55831https://curecurrent.com/trials/alpha-radiation-emitters-device-dart-for-the-treatment-of-locally-recurrent-prostate-cancer-55832https://curecurrent.com/trials/accuracy-of-18f-rhpsma-7-3-pet-mri-for-prediction-of-lymph-node-metastasis-in-localized-high-risk-prostate-cancer-55833https://curecurrent.com/trials/a-dose-optimization-study-of-enzalutamide-in-elderly-patients-with-advanced-prostate-cancer-55834https://curecurrent.com/trials/evaluation-of-hypnosis-in-virtual-reality-on-the-anxiety-of-patients-with-metastatic-prostate-cancer-over-chemotherapy-55835https://curecurrent.com/trials/a-study-of-chemoimmunotherapy-for-the-treatment-of-men-with-neuroendocrine-or-aggressive-variant-metastatic-prostate-can-55836https://curecurrent.com/trials/a-trial-of-shr3680-in-prostate-cancer-patients-who-are-candidates-for-radical-prostatectomy-55837https://curecurrent.com/trials/closed-system-bladder-irrigation-to-reduce-urinary-tract-infections-after-endoscopic-urologic-surgery-iris-trial-55838https://curecurrent.com/trials/prostate-cancer-patient-empowerment-program-55839https://curecurrent.com/trials/targeted-alpha-therapy-with-225actinium-prostate-specific-membrane-antigen-psma-i-t-of-castration-resistant-prostate-can-55840https://curecurrent.com/trials/a-pilot-study-of-ultra-high-dose-hypofractionated-or-single-dose-radiotherapy-for-intermediate-risk-prostate-cancer-55841https://curecurrent.com/trials/active-surveillance-snep-assay-registry-trial-for-prostate-cancer-55842https://curecurrent.com/trials/impact-of-a-multimodal-prehabilitation-program-before-robotic-assisted-radical-prostatectomy-55843https://curecurrent.com/trials/adaptive-androgen-deprivation-and-docetaxel-in-metastatic-castration-sensitive-prostate-cancer-55844https://curecurrent.com/trials/clinical-trial-of-green-tea-catechins-in-men-on-active-surveillance-55845https://curecurrent.com/trials/using-a-mhealth-app-to-improve-quality-of-life-outcomes-in-black-prostate-cancer-survivors-55846https://curecurrent.com/trials/a-study-of-terbium-161-161tb-rad402-in-participants-with-crpc-55847https://curecurrent.com/trials/patient-preference-between-cabazitaxel-and-docetaxel-in-metastatic-castrate-resistant-prostate-cancer-55848https://curecurrent.com/trials/fully-hybrid-18f-psma-pet-mri-as-one-stop-approach-for-the-diagnosis-of-clinically-significant-prostate-cancer-55849https://curecurrent.com/trials/study-of-drug-1-enzalutamide-plus-drug-2-relacorilant-for-patients-with-prostate-cancer-55850https://curecurrent.com/trials/effects-of-muscadine-grape-extract-in-men-with-prostate-cancer-on-androgen-deprivation-therapy-55851https://curecurrent.com/trials/contributions-of-a-paramedical-approach-in-the-prevention-and-treatment-of-side-effects-associated-with-radical-prostate-55852https://curecurrent.com/trials/a-study-to-evaluate-the-tolerance-and-pharmacokinetics-of-tqb3720-tablets-55853https://curecurrent.com/trials/autologous-gamma-delta-t-cells-to-target-prostate-stem-cell-antigen-in-mcrpc-55854https://curecurrent.com/trials/quality-of-life-in-prostate-cancer-patients-55855https://curecurrent.com/trials/prostate-cancer-with-oligometastatic-relapse-combining-stereotactic-ablative-radiotherapy-and-durvalumab-medi4736-55856https://curecurrent.com/trials/prevalence-of-the-c-853delt-mutation-of-the-hoxb13-gene-in-prostate-cancer-in-martinique-55857https://curecurrent.com/trials/adjuvant-curcumin-to-assess-recurrence-free-survival-in-patients-who-have-had-a-radical-prostatectomy-55858https://curecurrent.com/trials/real-world-use-of-lutetium-177lu-vipivotide-tetraxetan-in-china-psmareal-cn-55859https://curecurrent.com/trials/salvage-moderate-hypofractionated-versus-ultrahypofractionated-radiotherapy-for-biochemical-recurrence-after-radical-pro-55860https://curecurrent.com/trials/imperial-prostate-9-atlas-approaches-to-long-term-active-surveillance-55861https://curecurrent.com/trials/fdg-pet-guided-metastasis-directed-radiation-therapy-for-the-treatment-of-metastatic-hormone-sensitive-prostate-cancer-t-55862https://curecurrent.com/trials/newpromri-pathway-a-new-prostate-magnetic-resonance-imaging-mri-pathway-55863https://curecurrent.com/trials/outpatient-laparoscopic-radical-prostatectomy-55864https://curecurrent.com/trials/study-of-psma-targeted-18f-dcfpyl-pet-ct-for-the-detection-of-clinically-significant-prostate-cancer-55865https://curecurrent.com/trials/spect-imaging-for-pharmacokinetics-and-dosimetry-towards-treatment-optimization-55866https://curecurrent.com/trials/sbrt-boost-for-unfavorable-prostate-cancer-55867https://curecurrent.com/trials/acceptability-of-artificial-intelligence-in-the-diagnosis-of-prostate-cancer-55868https://curecurrent.com/trials/local-ablative-therapy-for-hormone-sensitive-oligometastatic-prostate-cancer-55869https://curecurrent.com/trials/177-lupsma-617-vs-docetaxel-in-metastatic-castration-resistant-and-psma-positive-prostate-cancer-55870https://curecurrent.com/trials/ffoct-for-the-diagnosis-of-prostate-cancer-55871https://curecurrent.com/trials/effect-of-education-on-treatment-decision-making-for-patients-with-prostate-cancer-on-chronic-hormone-treatments-55872https://curecurrent.com/trials/educational-intervention-in-increasing-knowledge-about-prostate-cancer-in-high-risk-neighborhoods-55873https://curecurrent.com/trials/evaluating-in-home-cancer-therapy-versus-in-clinic-cancer-therapy-in-black-men-with-locally-advanced-biochemically-recur-55874https://curecurrent.com/trials/optimizing-timing-of-rhpsma-7-3-18f-for-assessing-site-s-of-recurrent-disease-following-radical-prostatectomy-55875https://curecurrent.com/trials/exploration-of-treatment-effect-of-novel-hormone-therapy-combined-with-local-treatment-based-on-psma-pet-ct-evaluation-i-55876https://curecurrent.com/trials/plasma-exorna-based-liquid-biopsy-to-diagnose-clinically-significant-prostate-cancer-55877https://curecurrent.com/trials/rezvilutamide-with-radical-prostatectomy-and-metastasis-directed-therapy-in-oligometastatic-prostate-cancer-55878https://curecurrent.com/trials/molecular-imaging-informed-radiation-dose-escalation-to-sites-of-recurrent-disease-and-de-escalation-to-uninvolved-areas-55879https://curecurrent.com/trials/hypo-fractionated-versus-conventional-imrt-in-unfavorable-intermediate-and-high-risk-prostate-cancer-55880https://curecurrent.com/trials/targeting-resistant-prostate-cancer-with-atr-and-parp-inhibition-trap-trial-55881https://curecurrent.com/trials/supervised-three-month-exercise-program-in-men-with-prostate-cancer-receiving-androgen-deprivation-therapy-55882https://curecurrent.com/trials/mechanisms-predictors-and-social-determinants-of-cardiotoxicity-in-prostate-cancer-55883https://curecurrent.com/trials/utility-of-18f-rhpsma-7-3-in-the-diagnosis-of-prostate-cancer-after-focal-gland-treatment-55884https://curecurrent.com/trials/a-study-evaluating-177lu-lu-psma-617-vs-a-change-of-androgen-receptor-directed-therapy-in-taxane-treatment-naive-chinese-55885https://curecurrent.com/trials/comparing-the-reliability-of-expressed-prostatic-secretion-eps-and-post-massage-urine-pmu-for-the-prediction-of-prostate-55886https://curecurrent.com/trials/cardiac-mri-in-measuring-the-impact-of-anti-androgen-treatment-on-cardiac-function-in-patients-with-prostate-cancer-55887https://curecurrent.com/trials/neoadjuvant-lu-177-psma-617-in-patients-with-high-risk-localized-prostate-cancer-undergoing-radical-prostatectomy-55888https://curecurrent.com/trials/consolidative-prostate-radiotherapy-in-metastatic-prostate-cancer-55889https://curecurrent.com/trials/dose-de-escalation-in-prostate-radiotherapy-using-an-mr-linac-in-2-fractions-55890https://curecurrent.com/trials/novel-ack1-inhibitor-r-9b-in-patients-with-prostate-cancer-55891https://curecurrent.com/trials/active-surveillance-with-or-without-apalutamide-treatment-in-low-risk-prostate-cancer-55892https://curecurrent.com/trials/pulse-registry-for-patients-receiving-lutetium-177lu-vipivotide-tetraxetan-55893https://curecurrent.com/trials/hispanic-adapted-and-culturally-relevant-exercising-together-55894https://curecurrent.com/trials/radiomics-of-treatment-naive-prostate-cancer-patients-on-multiparametric-mri-for-risk-stratification-and-treatment-outco-55895https://curecurrent.com/trials/18f-psma-pet-ct-versus-ct-alone-in-assessment-of-prostatic-cancer-patients-55896https://curecurrent.com/trials/psma-pet-deep-radiomic-biomarkers-of-progression-and-response-prediction-in-prostate-cancer-55897https://curecurrent.com/trials/treatment-of-high-risk-prostate-cancer-guided-by-novel-diagnostic-radio-and-molecular-tracers-55898https://curecurrent.com/trials/faecal-incontinence-in-prostate-cancer-survivors-treated-whith-radiotherapy-55899https://curecurrent.com/trials/a-real-world-study-of-characteristics-treatment-patterns-and-clinical-outcomes-among-lutetium-177-vipivotide-tetraxetan-55900https://curecurrent.com/trials/apalutamide-in-treating-patients-with-prostate-cancer-before-radical-prostatectomy-55901https://curecurrent.com/trials/a-study-of-opevesostat-mk-5684-in-china-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc-mk-5684-55902https://curecurrent.com/trials/psma-pet-ct-based-multimodal-model-for-predicting-response-to-first-line-therapy-in-mhspc-55903https://curecurrent.com/trials/mannitol-versus-nitroglycerin-for-kidney-injury-prevention-in-robotic-assisted-radical-prostatectomy-or-cystectomy-55904https://curecurrent.com/trials/a-phase-ii-clinical-two-stage-study-of-transcranial-magnetic-stimulation-in-preventing-postoperative-delirium-in-elderly-55905https://curecurrent.com/trials/mechanisms-of-resistance-to-psma-radioligand-therapy-55906https://curecurrent.com/trials/prostate-stereotactic-radiation-and-radio-induced-lymphocyte-apoptosis-for-predicting-late-toxicities-in-prostate-cancer-55907https://curecurrent.com/trials/predictors-of-mental-health-in-men-with-prostate-cancer-undergoing-a-patient-empowerment-program-55908https://curecurrent.com/trials/pre-prostatectomy-mri-guided-stereotactic-body-radiotherapy-for-high-risk-prostate-cancer-trial-prepare-sbrt-55909https://curecurrent.com/trials/evaluation-of-an-active-surveillance-protocol-for-prostate-cancer-in-the-brazilian-population-55910https://curecurrent.com/trials/use-of-a-biodegradable-balloon-for-the-treatment-of-prostate-cancer-by-intensity-modulated-radiotherapy-biopro-rcmi-55911https://curecurrent.com/trials/darolutamide-adt-as-neoadjuvant-therapy-in-high-risk-very-high-risk-localized-prostate-cancer-55912https://curecurrent.com/trials/64cu-grip-b-in-patients-with-advanced-malignancies-55913https://curecurrent.com/trials/pet-imaging-study-of-89zr-dfo-ys5-in-men-with-prostate-cancer-55914https://curecurrent.com/trials/insight-pca-mri-and-phi-guided-risk-adapted-strategy-for-prostate-cancer-diagnosis-55915https://curecurrent.com/trials/a-multicenter-prospective-study-on-the-prognostic-value-of-psma-pet-in-patients-with-newly-diagnosed-treatment-na-ve-pro-55916https://curecurrent.com/trials/long-term-follow-up-of-avencell-sponsored-car-t-cell-clinical-trials-55917https://curecurrent.com/trials/prostate-risk-or-radiology-assessment-non-inferiority-design-upfront-mri-or-risk-calculator-in-men-with-suspected-prosta-55918https://curecurrent.com/trials/feasibility-study-of-urinary-cfdna-analysis-as-a-non-invasive-monitoring-tool-in-patients-with-prostate-or-bladder-cance-55919https://curecurrent.com/trials/oxybutynin-er-to-promote-early-continence-recovery-after-robotic-prostatectomy-a-randomized-controlled-trial-55920https://curecurrent.com/trials/prospective-clinical-study-comparing-proms-after-adaptive-or-conventional-radiotherapy-in-prostate-cancer-55921https://curecurrent.com/trials/apalutamide-abiraterone-acetate-and-prednisone-in-treating-participants-with-metastatic-castration-resistant-prostate-ca-55922https://curecurrent.com/trials/two-fraction-proton-therapy-with-mri-guidance-for-prostate-cancer-a-phase-ii-trial-55923https://curecurrent.com/trials/radium-223-in-biochemically-recurrent-prostate-cancer-55924https://curecurrent.com/trials/hypofractionated-stereotactic-boost-in-prostate-cancer-55925https://curecurrent.com/trials/re-treatment-with-177lu-psma-617-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-re-lupsma-trial-55926https://curecurrent.com/trials/effects-of-a-neuroscience-based-technique-on-cancer-patients-announced-of-a-palliative-disease-progression-and-partners-55927https://curecurrent.com/trials/neoadjuvant-lu-psma-radioligand-therapy-and-ipilimumab-in-men-with-very-high-risk-prostate-cancer-55928https://curecurrent.com/trials/abiraterone-and-prednisone-or-darolutamide-for-the-treatment-of-advanced-prostate-cancer-55929https://curecurrent.com/trials/a-phase-i-clinical-study-of-glr2037-in-patients-with-advanced-prostate-cancer-55930https://curecurrent.com/trials/a-study-investigating-the-pharmacokinetics-pharmacodynamics-efficacy-and-safety-of-teverelix-dp-a-gonadotropin-releasing-55931https://curecurrent.com/trials/comparison-of-tb-pb-and-tb-6sb-for-prostate-cancer-diagnosis-55932https://curecurrent.com/trials/rituximab-neoadjuvant-therapy-in-patients-with-prostate-cancer-scheduled-to-undergo-radical-prostatectomy-55933https://curecurrent.com/trials/procare-prostate-cancer-real-world-evidence-registry-55934https://curecurrent.com/trials/intensive-cholesterol-lowering-and-cd8-t-cells-in-prostate-cancer-55935https://curecurrent.com/trials/safety-and-efficacy-of-21-gy-23-gy-and-25-gy-for-high-dose-rate-hdr-prostate-brachytherapy-55936https://curecurrent.com/trials/evaluation-of-tumor-control-based-on-serial-multiparametric-mri-and-post-treatment-biopsies-for-patients-treated-with-do-55937https://curecurrent.com/trials/supraphysiologic-testosterone-priming-induces-darolutamide-extended-response-55938https://curecurrent.com/trials/a-study-called-aramon-to-learn-to-what-extent-does-study-treatment-with-darolutamide-affects-testosterone-levels-in-men-55939https://curecurrent.com/trials/effects-of-music-therapy-on-anxiety-and-distress-levels-during-radionuclide-treatment-in-prostate-cancer-patients-55940https://curecurrent.com/trials/trial-of-ptvg-hp-nivo-targeted-ablation-of-resistant-lesions-in-non-castrate-recurrentompc-55941https://curecurrent.com/trials/stereotactic-mri-guided-radiation-therapy-for-localized-prostate-cancer-55942https://curecurrent.com/trials/priapus-pca-study-stereotactic-body-radiation-therapy-sbrt-and-androgen-deprivation-therapy-adt-impact-on-sexual-functio-55943https://curecurrent.com/trials/a-study-looking-at-a-new-nerve-surgery-to-help-men-regain-erections-after-prostate-cancer-surgery-55944https://curecurrent.com/trials/a-study-of-tazemetostat-with-enzalutamide-or-abiraterone-prednisone-in-participants-with-advanced-prostate-cancer-55945https://curecurrent.com/trials/comparing-a-new-psma-imaging-agent-to-mri-for-detecting-prostate-cancer-beacon-trial-55946https://curecurrent.com/trials/phase-2-randomized-trial-of-flexible-dosing-schedule-of-177lu-psma-617-for-the-treatment-of-metastatic-castration-resist-55947https://curecurrent.com/trials/neoadjuvant-high-dose-rate-brachytherapy-prior-to-radical-prostatectomy-in-patients-with-prostate-cancer-55948https://curecurrent.com/trials/prostate-cancer-patients-treated-with-alternative-radiation-oncology-strategies-55949https://curecurrent.com/trials/together-stronger-a-family-centered-lifestyle-intervention-for-black-prostate-cancer-survivors-and-their-caregivers-55950https://curecurrent.com/trials/a-prospective-comparative-study-of-outcomes-with-proton-and-photon-radiation-in-prostate-cancer-55951https://curecurrent.com/trials/molecular-studies-and-clinical-correlations-in-human-prostatic-disease-55952https://curecurrent.com/trials/the-effect-of-deep-versus-moderate-muscle-relaxants-in-men-during-and-after-robotic-surgery-for-prostate-cancer-55953https://curecurrent.com/trials/palbociclib-in-patients-with-metastatic-castration-resistant-prostate-cancer-55954https://curecurrent.com/trials/comeback-from-long-course-androgen-deprivation-therapy-adt-with-relugolix-and-darolutamide-cleared-55955https://curecurrent.com/trials/mri-guided-sbrt-for-localized-prostate-cancer-55956https://curecurrent.com/trials/effects-of-relugolix-vs-leuprolide-on-cardiac-function-in-patients-with-prostate-cancer-55957https://curecurrent.com/trials/patient-decision-making-about-precision-oncology-in-veterans-with-advanced-prostate-cancer-55958https://curecurrent.com/trials/hormone-therapy-radiation-therapy-and-steroid-17alpha-monooxygenase-tak-700-in-treating-patients-with-high-risk-prostate-55959https://curecurrent.com/trials/radiation-therapy-with-or-without-androgen-deprivation-therapy-in-treating-patients-with-prostate-cancer-55960https://curecurrent.com/trials/combined-psma-pet-ct-and-mri-staging-in-intermediate-and-high-risk-patients-prostata-cancer-combine-p-55961https://curecurrent.com/trials/optimizing-active-surveillance-in-low-risk-prostate-cancer-a-pilot-study-55962https://curecurrent.com/trials/prostate-hypoxia-faza-55963https://curecurrent.com/trials/stratagen-quantitative-prostate-mri-platform-pilot-study-55964https://curecurrent.com/trials/transrectal-tumour-oxygen-us-army-55965https://curecurrent.com/trials/study-of-pharmacologic-manipulation-of-age-advanced-glycation-endproducts-levels-in-prostate-cancer-patients-receiving-a-55966https://curecurrent.com/trials/prostate-cancer-genius-app-education-and-home-based-psa-screening-for-african-american-men-55967https://curecurrent.com/trials/turkish-version-of-the-ucla-prostate-cancer-index-55968https://curecurrent.com/trials/interstitial-brachytherapy-with-or-without-external-beam-radiation-therapy-in-treating-patients-with-prostate-cancer-55969https://curecurrent.com/trials/prostate-cancer-screening-a-pilot-study-55970https://curecurrent.com/trials/erectile-function-preservation-for-prostate-cancer-radiation-therapy-erect-55971https://curecurrent.com/trials/mr-guided-tumour-boost-55972https://curecurrent.com/trials/utrecht-prostate-cohort-for-cancer-treatment-intervention-studies-and-long-term-evaluation-55973https://curecurrent.com/trials/timing-of-post-prostatectomy-psma-imaging-55974https://curecurrent.com/trials/relugolix-enzalutamide-study-in-high-risk-prostate-cancer-55975https://curecurrent.com/trials/t-reg-function-changes-a-novel-immune-regulatory-effect-underlying-benefit-of-statin-use-on-lethal-prostate-cancer-55976https://curecurrent.com/trials/vasomotor-symptom-alleviation-through-acupuncture-in-patients-with-prostate-cancer-55977https://curecurrent.com/trials/a-study-of-patient-characteristics-treatment-patterns-and-outcomes-among-patients-treated-with-177lu-psma-617-55978https://curecurrent.com/trials/collection-and-measurement-of-biomarkers-in-prostate-cancer-radiotherapy-patients-55979https://curecurrent.com/trials/sram-study-postate-cancer-55980https://curecurrent.com/trials/using-mri-to-identify-areas-to-receive-lower-doses-of-radiation-treatment-in-men-with-prostate-cancerdose-mapping-to-pre-55981https://curecurrent.com/trials/a-trial-of-niraparib-in-platinum-sensitive-castration-resistant-prostate-cancer-with-dna-repair-defects-55982https://curecurrent.com/trials/occupational-situation-and-return-to-work-of-urological-patients-55983https://curecurrent.com/trials/cancer-literacy-education-and-awareness-resources-for-prostate-care-55984https://curecurrent.com/trials/sense-of-coherence-and-quality-of-life-in-prostate-cancer-patients-treated-with-radical-radiotherapy-55985https://curecurrent.com/trials/psma-pet-additive-value-for-prostate-cancer-diagnosis-in-men-with-negative-equivocal-mri-55986https://curecurrent.com/trials/biopsy-collection-for-men-undergoing-brachytherapy-for-prostate-cancer-55987https://curecurrent.com/trials/mri-guided-radiation-therapy-for-the-treatment-of-high-risk-prostate-cancer-55988https://curecurrent.com/trials/a-study-of-shr3680-hs-20093-and-shr2554-in-subjects-with-prostate-cancer-55989https://curecurrent.com/trials/rezvilutamide-for-high-risk-prostate-cancer-after-surgery-55990https://curecurrent.com/trials/antiandrogen-therapy-with-or-without-axitinib-before-surgery-in-treating-patients-with-previously-untreated-prostate-can-55991https://curecurrent.com/trials/behavioral-exercise-training-to-reduce-cardiovascular-disease-risk-55992https://curecurrent.com/trials/validation-study-on-the-impact-of-decipher-testing-vandaam-study-55993https://curecurrent.com/trials/psma-pet-imaging-for-detecting-early-metastatic-prostate-cancer-in-men-w-high-decipher-test-scores-55994https://curecurrent.com/trials/mri-screening-in-men-at-high-risk-of-developing-prostate-cancer-55995https://curecurrent.com/trials/randomized-phase-ii-trial-of-salvage-radiotherapy-for-prostate-cancer-in-4-weeks-v-2-weeks-55996https://curecurrent.com/trials/study-of-inkmune-in-patients-with-mcrpc-care-prostate-55997https://curecurrent.com/trials/bicalutamide-implants-biolen-with-radiation-therapy-in-patients-with-localized-prostate-cancer-55998https://curecurrent.com/trials/lutetium-177-psma-617-in-oligo-metastatic-hormone-sensitive-prostate-cancer-55999https://curecurrent.com/trials/re-fit-remote-exercise-for-physical-function-in-wtc-responders-with-prostate-cancer-56000